hg_229225.1

Basic information about the TSS

---

TSS ID: hg_229225.1 Species: human Chr: chr4		Start: 77075589 End: 77075606 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000515790.1 Distance: -14 GeneID: 10983 HGNC/MGI_ID: HGNC:1595 UniProt_ID:

Gene_name: cyclin I Gene_symbol: CCNI Gene_synonyms: CCNI1 Gene_source: HGNC:1595

TATA-Box annotation

---

Distance to TSS:	374
Nearest PromoterID:	NM_001348135
Entrez ID:	10983
Nearest Unigene:	Hs.518827
Nearest Refseq:	NM_006835
Nearest Ensembl:	ENSG00000118816
Gene Name:	cyclin I
Gene Alias:	CCNI1|CYC1|CYI
Gene Description:	cyclin I
Gene Type:	protein-coding
CpG%:	0.14
GC%:	0.736318
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CCNI p2@CCNI p3@CCNI p4@CCNI p5@CCNI
Sample		p1@CCNI	p2@CCNI	p3@CCNI	p4@CCNI	p5@CCNI
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	42.66	3.31	3.31	0.97	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	44.51	3.84	3.03	1.42	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	46.49	2.70	3.47	0.96	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	36.59	1.25	1.46	0.62	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	44.32	1.57	3.60	0.45	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	44.38	1.94	2.33	0.19	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	59.05	2.18	3.92	0.65	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	30.76	1.45	1.45	0.48	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	38.26	2.14	3.42	0.43	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	52.75	1.74	5.22	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	46.49	4.85	9.70	1.62	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	58.95	2.03	4.47	1.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	275.32	37.40	0.64	2.26	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	241.31	21.05	0.90	1.95	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	254.68	25.69	0.22	2.63	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	243.69	33.20	0.25	2.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	250.51	27.74	0.87	1.53	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	205.85	27.42	0.84	0.00	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	161.01	22.93	0.53	1.07	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	218.44	24.67	0.75	1.35	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	200.75	17.64	1.07	3.21	1.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	211.98	21.41	1.04	3.11	0.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	208.36	20.81	0.65	2.33	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	226.89	27.66	0.24	2.18	2.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	244.32	24.25	0.26	1.03	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	184.84	24.37	0.63	1.90	1.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	195.06	18.68	1.10	2.20	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	224.44	27.58	0.94	1.89	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	166.85	20.19	0.97	1.13	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	228.92	19.91	0.90	2.17	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	184.43	24.91	1.05	1.05	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	191.08	29.50	0.59	0.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	144.98	20.89	0.84	1.48	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	166.75	24.25	1.81	1.81	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	200.08	28.24	0.56	1.87	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	211.36	21.85	0.38	0.77	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	208.67	23.91	1.02	1.64	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	169.05	24.18	0.60	1.01	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	200.69	31.87	0.81	2.70	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	164.92	24.97	0.48	1.92	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	151.27	31.76	1.18	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	157.23	31.33	0.73	1.76	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	195.92	35.85	0.63	1.05	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	203.32	27.27	1.05	0.87	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	193.55	23.89	0.80	1.20	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	193.56	38.62	0.47	2.56	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	187.13	40.78	0.24	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	181.51	38.15	0.89	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	176.90	41.17	0.96	2.39	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	171.26	27.70	1.21	1.21	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	233.24	15.17	1.23	2.66	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	244.17	16.68	1.11	1.78	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	195.89	97.95	0.00	41.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	296.31	15.26	0.71	1.06	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	225.67	8.95	0.99	2.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	139.26	47.82	5.03	4.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	197.93	12.86	2.76	3.67	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	405.14	18.80	0.97	1.94	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	343.33	17.99	0.96	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	247.69	25.15	1.57	1.57	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	375.79	12.69	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	343.76	11.78	0.56	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	328.81	66.88	2.39	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	225.61	16.65	1.02	1.02	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	360.66	21.77	0.32	0.65	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	324.81	14.91	0.71	1.06	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	145.48	64.66	0.00	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	157.95	15.79	0.00	23.69	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	357.35	13.65	0.49	0.49	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	280.66	7.93	0.00	3.47	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	282.41	12.67	0.00	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	331.52	21.20	0.99	1.66	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	477.93	25.68	0.93	3.09	1.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	469.62	22.32	1.22	1.83	0.92
Adipocyte - breast, donor1	11376-118A8	148.25	19.80	1.27	2.38	0.16
Adipocyte - breast, donor2	11327-117E4	70.27	12.19	0.48	1.93	0.64
Adipocyte - omental, donor1	11473-119C6	198.22	27.48	1.40	1.02	0.25
Adipocyte - omental, donor2	11474-119C7	60.55	7.47	0.00	1.49	0.75
Adipocyte - omental, donor3	11475-119C8	106.50	14.07	0.67	0.67	0.33
Adipocyte - perirenal, donor1	11476-119C9	72.09	14.04	0.00	1.91	1.91
Adipocyte - subcutaneous, donor1	11259-116F8	16.49	6.60	0.00	2.20	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	95.74	5.87	1.35	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	105.13	12.86	0.35	1.39	1.04
Adipocyte differentiation, day04, donor1	13019-139D4	195.96	31.49	0.98	0.59	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	114.79	7.72	0.26	0.51	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	82.52	17.28	1.12	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	112.27	14.70	0.59	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	160.79	18.42	0.72	0.16	0.64
Adipocyte differentiation, day08, donor2	13023-139D8	115.22	14.20	0.97	0.65	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	73.05	14.93	0.53	1.60	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	87.92	10.57	0.00	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	49.49	4.99	0.83	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	79.87	8.79	0.75	1.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	55.63	11.78	0.98	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	65.77	5.78	2.44	0.30	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	72.05	4.64	0.66	0.88	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	39.09	3.59	0.00	0.72	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	95.84	7.19	0.00	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	101.11	4.68	1.26	0.36	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	97.06	8.37	0.00	3.35	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	96.56	13.35	1.03	1.23	0.82
Anulus Pulposus Cell, donor1	11248-116E6	135.59	19.57	1.83	2.98	1.14
Anulus Pulposus Cell, donor2	11463-119B5	84.00	11.51	0.49	1.71	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	63.80	13.48	0.45	0.45	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	50.36	13.02	0.43	0.43	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	53.51	14.98	0.00	0.00	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	53.81	8.07	0.30	1.20	1.20
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	48.06	3.79	0.00	2.53	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	79.21	5.94	0.66	3.30	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	45.48	8.12	0.00	0.32	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	43.20	11.65	0.00	0.49	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	52.26	9.50	0.00	0.59	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	57.63	13.56	0.00	0.00	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	60.96	13.06	0.00	0.73	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	58.93	5.02	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	66.72	8.73	0.82	1.15	0.66
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	49.13	21.84	1.36	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	94.85	6.63	0.30	0.00	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	46.08	13.93	0.00	0.54	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	61.78	12.47	0.38	1.32	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	79.38	9.62	1.07	1.34	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	52.67	11.71	1.95	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	55.23	10.45	0.17	1.66	0.83
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	63.64	12.01	1.20	1.20	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	46.02	10.62	0.00	10.62	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	62.61	11.66	1.20	0.69	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	75.51	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	49.03	8.25	0.00	0.49	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	59.95	16.32	0.76	1.14	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	43.61	16.96	0.00	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	54.15	13.11	0.00	0.57	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	48.74	12.40	1.07	1.50	1.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	83.62	9.55	0.52	1.03	1.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	50.21	15.48	1.41	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	49.84	8.36	0.00	1.29	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	62.07	7.85	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	35.68	11.11	0.58	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	66.84	9.33	0.90	0.30	1.81
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	100.98	10.69	0.00	1.19	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	41.70	11.70	0.00	1.53	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	63.67	11.97	0.76	2.55	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	71.80	12.07	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	48.76	13.38	0.43	1.73	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	57.58	10.58	0.21	0.85	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	80.90	6.96	0.29	0.87	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	54.79	17.95	0.94	0.94	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	55.10	9.66	0.51	1.70	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	67.17	6.95	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	46.48	16.90	4.23	4.23	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	52.53	7.72	0.64	0.86	0.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	79.42	6.62	0.60	2.41	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	59.05	8.02	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	61.38	8.74	1.15	1.15	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	76.51	10.20	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	73.22	4.83	0.25	0.51	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	53.67	12.39	1.03	0.41	1.03
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	88.13	10.71	0.00	0.31	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	65.01	11.95	0.00	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	71.84	10.20	1.33	1.11	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	79.34	6.10	0.00	3.05	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	34.34	16.06	0.00	1.66	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	60.11	11.12	0.79	0.53	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	85.05	8.72	0.36	1.09	0.73
Astrocyte - cerebellum, donor1	11500-119F6	65.95	10.07	2.21	1.47	0.12
Astrocyte - cerebellum, donor2	11580-120F5	84.72	10.61	1.71	0.86	0.68
Astrocyte - cerebellum, donor3	11661-122F5	122.70	16.57	1.68	1.26	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	127.93	14.64	5.23	0.70	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	124.24	15.04	2.59	1.62	0.97
Astrocyte - cerebral cortex, donor3	11392-118C6	142.90	5.52	1.94	1.49	1.04
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	128.91	16.51	1.15	1.38	1.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	130.79	13.41	2.00	1.63	1.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	131.09	11.83	0.91	0.91	1.25
Basophils, donor1	12241-129G9	213.93	13.86	1.05	1.05	0.00
Basophils, donor2	12242-129H1	216.12	19.84	0.36	2.89	0.00
Basophils, donor3	12243-129H2	178.16	22.05	1.18	0.29	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	105.65	10.13	1.08	0.86	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	82.75	9.14	0.00	0.46	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	208.03	21.52	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	83.48	10.67	0.00	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	90.25	14.35	0.21	0.21	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	132.88	22.80	0.92	3.22	1.38
Bronchial Epithelial Cell, donor7	11769-123I5	119.84	9.72	0.54	3.60	1.62
Burkitt's lymphoma cell line:DAUDI	10422-106C8	207.55	21.02	1.85	1.13	1.03
Burkitt's lymphoma cell line:RAJI	10476-106I8	190.98	16.54	3.26	0.47	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	240.15	26.22	0.64	0.96	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	103.42	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	141.45	15.22	3.38	1.69	1.69
CD14+ Monocytes, donor2	11305-117B9	197.85	25.80	2.78	1.30	1.11
CD14+ Monocytes, donor3	11381-118B4	232.05	10.98	2.85	0.66	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	138.69	21.51	0.28	0.57	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	278.62	21.23	1.14	1.14	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	272.85	26.30	0.66	1.64	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	254.41	32.67	1.73	2.60	1.01
CD14+ monocytes - mock treated, donor2	11873-125C1	232.64	16.90	0.60	0.30	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	231.68	17.29	1.42	1.18	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	199.87	26.28	1.84	0.50	0.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	201.21	12.97	0.83	1.10	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	158.67	12.64	1.74	0.99	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	192.08	19.19	1.57	2.15	0.98
CD14+ monocytes - treated with BCG, donor2	11870-125B7	181.79	21.01	1.07	0.53	0.89
CD14+ monocytes - treated with BCG, donor3	11880-125C8	150.60	5.66	0.22	1.52	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	147.73	25.99	0.94	0.70	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	154.18	13.73	2.64	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	124.25	7.77	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	200.81	32.72	1.78	4.46	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	185.38	16.56	1.60	2.59	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	137.62	8.12	1.87	2.29	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	221.69	35.69	1.37	0.92	1.14
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	150.88	5.43	1.13	0.45	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	152.32	16.15	1.31	2.18	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	228.37	24.48	1.08	2.96	1.08
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	231.51	24.95	0.70	1.05	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	218.41	18.52	2.10	2.10	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	162.77	19.84	1.10	1.84	0.55
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	213.47	13.39	1.76	1.06	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	189.09	9.21	1.75	1.32	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	190.42	23.54	0.70	3.14	0.70
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	175.06	12.64	1.12	2.23	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	195.93	6.25	1.72	3.02	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	189.18	20.88	2.87	2.46	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	126.56	5.10	1.85	1.16	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	130.38	4.41	1.62	0.70	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	111.82	5.45	1.09	2.40	1.09
CD14+CD16+ Monocytes, donor2	11801-124D1	137.44	26.80	1.62	0.92	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	99.64	7.80	1.08	1.73	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	195.74	31.14	0.93	2.18	0.78
CD14+CD16- Monocytes, donor2	11799-124C8	196.47	22.01	1.75	3.49	0.70
CD14+CD16- Monocytes, donor3	11910-125G2	195.10	6.47	1.78	2.45	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	94.41	21.95	0.26	1.79	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	149.52	29.20	0.44	1.54	1.32
CD14-CD16+ Monocytes, donor3	11911-125G3	142.33	6.74	1.47	2.32	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	189.00	40.65	2.03	4.06	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	216.95	29.15	1.36	1.36	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	190.55	22.78	3.11	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	149.78	34.65	1.60	1.07	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	286.26	43.96	1.61	4.82	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	182.50	32.99	0.70	4.21	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	215.70	26.67	1.57	3.92	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	197.74	26.37	1.32	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	327.94	30.41	2.47	4.93	0.82
CD19+ B Cells, donor2	11624-122B4	273.49	36.27	3.63	0.73	1.45
CD19+ B Cells, donor3	11705-123B4	292.80	32.31	1.51	2.52	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	144.65	5.66	0.40	2.83	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	125.44	9.19	2.00	2.40	0.80
CD34+ Progenitors, donor1	11545-120B6	66.27	19.08	0.00	1.00	1.00
CD34+ Progenitors, donor2	11625-122B5	67.42	19.10	0.56	2.25	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	169.09	21.04	1.50	1.13	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	188.96	21.42	1.80	1.13	0.23
CD4+ T Cells, donor1	11225-116C1	246.37	32.85	0.36	0.36	1.79
CD4+ T Cells, donor2	11306-117C1	284.75	42.25	1.22	6.12	1.84
CD4+ T Cells, donor3	11382-118B5	388.26	15.86	0.00	2.13	1.83
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	105.92	19.91	0.77	2.55	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	252.67	27.63	0.67	1.57	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	255.84	24.43	1.44	1.72	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	186.32	29.87	1.42	3.32	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	179.79	51.97	0.00	7.02	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	240.62	23.07	0.00	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	181.94	28.61	0.87	1.59	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	274.02	28.81	1.02	4.58	0.68
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	244.71	22.57	0.64	2.26	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	160.04	36.31	0.90	3.14	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	194.26	36.34	0.35	3.14	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	235.39	13.64	2.20	4.84	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	168.66	18.13	0.84	4.22	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	287.97	24.10	0.21	2.49	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	268.30	23.39	2.00	4.34	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	265.68	36.44	0.27	6.25	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	237.96	35.91	1.07	3.22	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	245.67	12.55	0.00	5.38	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	173.38	27.26	1.48	2.41	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	169.18	19.50	1.30	1.95	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	220.87	24.17	1.68	2.73	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	106.18	23.26	0.51	1.01	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	124.78	32.49	0.00	0.87	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	222.27	10.02	1.31	4.79	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	270.69	26.72	1.48	2.97	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	208.64	22.16	0.00	3.69	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	178.67	29.31	1.40	4.19	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	107.73	31.29	1.11	1.66	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	123.68	35.58	0.49	2.70	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	246.40	23.10	0.00	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	309.06	31.16	2.15	1.07	1.07
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	246.53	29.08	0.00	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	200.37	22.92	0.98	0.98	0.65
CD8+ T Cells, donor2	11307-117C2	193.35	28.16	0.38	3.38	3.75
CD8+ T Cells, donor3	11383-118B6	307.53	15.65	1.77	4.29	1.01
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	66.06	3.67	0.46	0.92	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	60.87	3.83	0.96	0.48	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	73.60	3.28	0.55	1.37	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	58.84	3.30	0.60	1.80	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	74.39	2.40	0.48	1.92	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	71.63	4.09	0.91	1.14	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	65.62	3.69	0.65	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	73.96	4.74	0.79	1.32	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	57.69	2.81	1.17	0.23	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	67.92	4.23	1.51	0.60	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	81.05	6.97	0.58	1.45	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	61.55	2.66	0.80	0.80	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	75.29	3.50	2.19	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	89.72	4.10	0.46	1.37	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	203.62	11.93	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	69.51	4.68	0.00	1.08	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	82.29	4.60	0.58	2.01	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	87.68	6.60	0.94	0.94	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	44.68	1.58	0.63	1.27	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	65.20	2.46	0.62	1.23	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	58.35	1.60	0.96	0.64	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	78.02	4.59	2.29	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	77.64	1.97	0.00	0.79	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	67.32	4.54	0.76	1.51	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	143.73	8.03	0.80	3.21	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	187.45	16.09	0.00	2.10	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	152.27	5.01	2.00	3.01	2.00
Cardiac Myocyte, donor1	11525-119I4	469.73	49.35	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	92.89	8.40	0.99	2.47	0.49
Cardiac Myocyte, donor3	11686-122I3	69.03	12.31	1.16	0.95	0.42
Chondrocyte - de diff, donor1	11261-116G1	138.32	24.96	0.35	0.69	0.00
Chondrocyte - de diff, donor2	11338-117F6	110.88	7.82	0.71	1.42	0.71
Chondrocyte - de diff, donor3	11410-118E6	132.10	12.74	1.02	3.64	1.37
Chondrocyte - re diff, donor2	11339-117F7	170.10	10.74	1.79	1.79	0.00
Chondrocyte - re diff, donor3	11411-118E7	130.62	5.26	0.40	3.64	1.62
Ciliary Epithelial Cells, donor1	11242-116D9	157.10	22.49	4.71	1.84	1.72
Ciliary Epithelial Cells, donor2	11323-117D9	104.96	25.01	1.71	1.07	1.28
Ciliary Epithelial Cells, donor3	11399-118D4	142.39	6.90	1.95	1.15	0.71
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	270.52	28.43	4.95	2.38	2.38
Corneal Epithelial Cells, donor1	11526-119I5	86.51	7.90	0.44	0.66	0.00
Corneal Epithelial Cells, donor2	11606-120I4	84.18	10.24	1.14	3.41	0.00
Corneal Epithelial Cells, donor3	11687-122I4	76.18	17.13	0.51	0.51	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	232.78	23.94	0.83	1.82	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	161.17	16.72	0.32	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	75.92	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	146.11	5.29	0.32	1.62	1.40
Dendritic Cells - plasmacytoid, donor1	11228-116C4	187.56	29.04	0.68	0.68	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	118.82	18.93	0.65	1.31	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	66.78	23.23	0.48	2.42	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	86.05	7.34	0.17	0.50	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	38.14	7.63	0.59	0.00	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	111.42	7.64	0.28	0.57	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	94.36	4.33	1.57	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	40.43	4.65	0.87	0.29	0.29
Endothelial Cells - Artery, donor2	11341-117F9	79.76	11.06	0.94	1.18	1.65
Endothelial Cells - Artery, donor3	11413-118E9	77.14	5.79	0.18	0.18	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	83.34	8.64	0.66	0.89	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	105.28	7.91	0.61	0.91	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	103.46	8.18	1.13	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	76.96	13.67	0.89	0.59	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	78.62	5.21	0.00	1.04	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	74.30	8.22	0.57	1.28	0.99
Endothelial Cells - Thoracic, donor1	11266-116G6	108.83	14.00	0.40	2.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	64.47	12.58	0.00	1.57	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	148.47	18.14	0.87	1.12	1.49
Endothelial Cells - Umbilical vein, donor2	11324-117E1	140.79	9.99	0.22	0.43	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	142.16	6.96	0.73	0.85	0.00
Endothelial Cells - Vein, donor1	11267-116G7	26.16	4.55	0.00	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	41.91	8.38	0.00	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	86.82	5.34	0.94	0.94	0.31
Eosinophils, donor1	12244-129H3	91.48	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	361.41	36.31	4.95	1.65	0.00
Eosinophils, donor3	12246-129H5	196.18	28.53	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	89.42	8.55	0.98	0.49	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	72.81	4.16	0.00	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	178.96	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	183.09	17.24	0.41	0.82	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	52.55	3.07	0.33	0.77	0.77
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	126.32	13.43	0.54	2.06	0.54
Fibroblast - Aortic Adventitial, donor1	11245-116E3	86.84	15.52	1.58	0.85	0.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	20.47	1.36	1.23	0.14	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	85.32	11.71	0.95	0.84	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	10.54	4.74	0.79	0.26	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	100.32	12.29	0.66	1.00	1.33
Fibroblast - Cardiac, donor1	11268-116G8	53.07	5.90	1.81	0.00	0.91
Fibroblast - Cardiac, donor2	11345-117G4	89.44	3.79	1.52	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	56.30	4.10	0.63	0.95	0.47
Fibroblast - Cardiac, donor4	11452-119A3	128.82	12.73	0.61	0.91	0.00
Fibroblast - Cardiac, donor5	11456-119A7	75.63	14.47	0.25	1.40	0.63
Fibroblast - Cardiac, donor6	11460-119B2	50.33	9.10	0.15	1.36	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	82.00	10.59	1.21	0.80	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	145.39	16.83	2.16	0.43	2.16
Fibroblast - Choroid Plexus, donor3	11653-122E6	92.28	11.72	0.00	1.46	4.39
Fibroblast - Conjunctival, donor1	11531-120A1	120.39	8.76	1.38	0.23	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	221.84	32.90	2.04	4.24	3.39
Fibroblast - Dermal, donor1	11269-116G9	47.19	8.92	0.47	0.70	0.47
Fibroblast - Dermal, donor2	11346-117G5	64.62	3.30	0.94	0.94	0.00
Fibroblast - Dermal, donor3	11418-118F5	79.18	7.86	0.36	1.45	0.97
Fibroblast - Dermal, donor4	11450-119A1	63.98	10.06	0.11	1.47	0.68
Fibroblast - Dermal, donor5	11454-119A5	57.74	10.99	0.70	1.22	0.52
Fibroblast - Dermal, donor6	11458-119A9	66.27	13.16	0.49	1.46	0.65
Fibroblast - Gingival, donor1	11237-116D4	115.78	16.45	1.25	0.42	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	140.96	25.15	0.79	1.31	0.79
Fibroblast - Gingival, donor2	11318-117D4	93.04	16.34	0.66	2.37	1.32
Fibroblast - Gingival, donor3	11394-118C8	197.63	10.44	2.13	0.68	0.87
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	191.16	19.74	3.12	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	142.02	17.27	0.18	1.06	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	89.17	13.25	0.94	0.78	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	93.71	13.25	1.49	0.95	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	177.50	34.23	2.12	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	121.97	19.60	1.90	0.29	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	105.67	14.86	1.50	0.27	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	126.70	17.88	1.10	1.32	0.55
Fibroblast - Gingival, donor9 (control)	11927-125I1	223.34	43.43	1.17	1.61	0.44
Fibroblast - Lung, donor1	11270-116H1	70.69	4.08	0.00	2.72	2.72
Fibroblast - Lung, donor2	11347-117G6	76.10	8.95	1.49	1.49	1.49
Fibroblast - Lung, donor3	11419-118F6	101.09	9.71	1.06	3.38	1.27
Fibroblast - Lymphatic, donor1	11506-119G3	41.65	11.66	0.00	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	57.34	13.99	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	57.09	9.52	0.84	1.12	0.28
Fibroblast - Mammary, donor1	11540-120B1	114.89	14.21	0.41	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	71.90	7.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	101.26	5.96	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	103.58	14.35	0.58	0.78	0.78
Fibroblast - Periodontal Ligament, donor2	11319-117D5	126.50	16.84	2.43	2.58	1.37
Fibroblast - Periodontal Ligament, donor3	11395-118C9	106.48	11.02	0.31	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	117.16	11.83	0.76	1.14	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	87.75	17.55	0.81	2.16	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	173.38	11.13	1.39	1.28	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	71.74	7.74	1.33	1.55	0.77
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	116.23	7.92	1.63	0.20	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	113.59	12.03	0.00	0.67	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	62.47	13.84	2.37	1.19	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	14.09	4.37	0.20	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	93.07	5.86	0.36	1.07	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	125.74	10.84	0.79	1.58	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	18.65	5.42	0.30	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	84.53	11.33	0.86	0.76	0.65
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	18.98	1.01	0.51	0.25	0.00
Fibroblast - skin normal, donor1	11553-120C5	102.22	6.23	0.49	0.98	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	37.29	4.01	1.00	0.00	0.20
Fibroblast - skin normal, donor2	11561-120D4	59.67	9.85	0.60	1.31	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	20.55	3.02	0.60	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	158.57	16.15	0.99	1.33	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	129.41	24.27	2.05	2.56	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	17.08	2.96	0.33	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	49.53	10.23	0.64	0.75	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	82.65	6.41	1.01	1.52	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	95.35	6.74	0.78	4.39	0.94
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	132.96	0.00	0.00	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	189.12	21.79	0.00	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	143.71	22.88	0.69	1.04	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	174.36	11.71	1.04	2.34	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	162.25	13.54	1.53	1.53	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	257.23	22.97	2.30	0.00	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	230.98	19.14	1.91	5.74	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	429.61	23.39	6.28	2.00	1.43
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	1163.14	101.75	11.31	2.76	2.21
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	594.11	53.66	4.11	1.14	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	591.42	32.49	5.94	1.39	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	1341.24	120.01	11.63	3.97	1.85
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	670.56	57.08	5.54	0.00	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	360.41	15.04	6.63	1.77	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	133.27	13.43	5.23	2.26	0.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	138.54	15.39	5.05	1.48	0.86
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	117.12	9.94	6.45	1.34	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	158.96	20.81	2.35	1.24	0.74
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	133.86	17.16	3.60	2.49	1.52
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	132.96	14.64	4.68	1.22	1.63
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	171.82	26.93	3.42	2.97	1.60
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	145.74	15.32	2.49	2.74	1.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	203.06	22.51	2.40	1.09	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	220.13	26.00	5.02	2.66	1.77
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	151.65	20.19	2.54	1.75	1.11
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	182.09	25.69	3.13	0.89	1.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	179.66	23.19	3.83	2.62	2.62
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	136.90	18.32	3.56	2.37	1.53
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	287.83	25.45	4.17	1.42	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	624.34	49.32	7.28	1.35	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	471.34	17.59	7.51	1.20	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	171.40	21.80	3.76	1.88	1.99
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	243.35	25.37	4.66	1.91	1.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	179.68	10.82	3.68	1.63	1.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	244.06	25.79	3.09	2.27	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	197.61	22.25	4.50	1.73	1.27
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	133.58	17.68	2.50	1.50	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	260.11	30.20	4.19	1.54	1.76
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	188.79	21.52	2.71	3.81	3.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	158.04	21.07	3.40	1.13	0.97
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	340.92	31.43	3.53	3.21	3.21
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	137.11	18.67	2.37	2.08	1.14
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	158.18	17.24	1.90	2.06	1.11
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	267.90	21.29	4.26	1.52	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	138.93	16.94	1.67	2.40	1.25
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	187.94	16.47	1.76	2.42	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	202.56	25.81	3.09	3.93	1.12
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	107.49	14.63	1.85	0.37	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	125.41	10.96	1.87	1.34	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	104.04	14.54	3.06	0.31	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	79.79	12.31	1.30	1.42	1.81
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	122.80	12.74	1.08	1.63	1.08
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	141.40	18.62	2.40	1.66	2.21
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	157.03	18.42	2.19	1.54	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	303.47	20.83	4.96	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	135.61	20.18	1.19	1.58	1.45
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	149.10	17.35	0.61	1.21	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	476.04	46.77	10.17	1.52	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	97.54	13.54	4.98	1.39	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	118.18	13.40	5.08	1.08	1.23
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	115.18	13.30	7.16	1.64	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	161.47	15.96	5.01	2.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	162.19	12.15	4.80	1.98	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	96.39	19.83	3.69	1.38	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	96.52	9.90	9.90	2.47	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	138.86	20.11	5.42	3.48	2.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	184.51	25.67	3.21	4.81	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	123.46	17.39	6.96	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	138.33	19.20	3.91	1.30	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	142.07	22.65	6.59	5.77	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	249.92	36.65	10.00	6.66	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	164.43	20.69	5.59	2.24	1.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	186.63	24.84	3.92	1.96	2.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	202.16	22.65	2.52	4.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	182.26	25.76	4.13	2.86	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	195.98	24.12	4.76	4.08	3.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	64.73	12.53	4.18	8.35	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	257.14	40.66	4.01	6.87	2.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	204.23	22.79	3.26	3.85	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	99.95	20.33	3.39	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	165.68	22.37	5.38	4.97	1.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	192.62	29.46	5.98	3.45	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	68.49	10.54	0.00	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	129.16	24.99	1.92	3.08	1.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	157.77	21.51	1.96	2.61	2.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	169.89	15.38	2.68	2.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	177.61	44.69	4.62	5.78	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	181.44	30.47	4.79	3.08	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	278.30	19.88	4.97	12.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	393.05	37.28	2.83	4.25	3.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	243.81	38.02	3.02	2.41	2.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	223.82	24.93	3.56	2.54	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	246.48	26.32	3.99	6.38	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	219.54	26.64	2.47	5.92	1.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	296.29	48.40	2.36	4.72	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	272.47	33.84	1.17	2.33	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	230.85	39.94	1.32	6.58	2.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	195.82	31.36	2.54	2.54	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	124.76	21.49	0.60	5.97	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	101.42	23.29	2.91	3.88	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	45.65	2.28	0.00	2.28	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	71.94	16.22	0.42	1.66	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	79.84	5.62	0.00	2.25	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	71.68	10.15	0.32	1.59	1.59
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	35.09	7.94	0.42	3.34	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	53.73	8.70	0.70	1.62	1.04
Hep-2 cells mock treated, biol_rep2	11899-125E9	45.91	4.90	0.68	1.01	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	46.18	7.74	0.46	0.68	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	48.75	8.09	0.66	1.09	0.55
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	41.05	6.45	1.07	1.07	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	37.89	5.81	1.08	1.51	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	57.16	10.34	1.37	1.37	0.75
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	50.61	7.03	1.03	0.69	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	45.49	5.13	0.64	0.64	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	97.37	5.60	0.00	1.12	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	114.69	12.12	0.43	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	97.82	0.00	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	106.87	9.52	2.47	0.71	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	102.44	5.09	1.45	0.73	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	58.57	5.59	1.05	1.57	0.52
Hepatocyte, donor1	11523-119I2	53.27	4.84	0.00	1.21	0.00
Hepatocyte, donor2	11603-120I1	95.88	12.93	1.08	1.08	1.08
Hepatocyte, donor3	11684-122I1	106.14	7.98	1.23	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	101.17	7.83	1.31	2.61	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	63.27	12.76	2.27	0.35	0.87
Iris Pigment Epithelial Cells, donor1	11530-119I9	77.93	13.03	2.33	1.78	0.69
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	38.21	3.18	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	0.00	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	34.61	5.54	1.38	2.77	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	22.52	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	48.70	0.00	5.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	16.24	16.24	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	60.02	5.00	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	43.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	27.79	6.62	0.00	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	43.24	5.54	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	41.91	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	55.43	7.56	0.63	1.26	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	38.67	4.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	102.44	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	50.39	9.04	1.94	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	33.81	1.61	3.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	52.15	9.78	4.07	1.63	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	38.62	7.56	2.52	1.26	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	57.87	11.25	0.80	3.21	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	28.62	4.62	1.85	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	52.87	4.72	0.94	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	29.93	4.53	0.00	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	117.94	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	38.74	4.30	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	43.20	6.35	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	65.72	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	42.09	3.83	1.28	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	18.23	3.65	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	52.84	5.00	1.43	0.71	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	39.82	6.64	0.00	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	55.56	8.03	0.62	0.31	0.93
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	42.14	3.51	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	15.72	0.00	0.00	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	26.42	6.26	1.39	0.00	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	46.47	8.85	0.00	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	25.94	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	39.24	5.23	0.87	0.00	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	38.25	6.75	0.00	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	24.39	3.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	39.47	9.60	1.07	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	27.71	4.16	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	14.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	35.90	5.52	0.00	0.00	2.76
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	33.28	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	48.64	7.40	2.11	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	164.42	15.59	0.98	0.90	0.57
Keratinocyte - epidermal, donor2	11349-117G8	77.89	5.86	0.59	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	142.84	6.91	0.76	2.75	2.27
Keratinocyte - oral, donor1	11251-116E9	229.31	30.54	1.36	2.72	1.70
Keratocytes, donor1	11527-119I6	182.92	13.41	1.72	0.34	1.38
Keratocytes, donor2	11607-120I5	64.45	11.72	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	171.12	14.82	0.99	1.98	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	107.70	4.40	4.40	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	45.31	9.71	2.16	2.16	0.00
Lens Epithelial Cells, donor2	11609-120I7	111.06	17.42	3.58	1.38	1.15
Lens Epithelial Cells, donor3	11690-122I7	95.56	10.80	2.42	0.00	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	120.83	7.23	0.59	1.30	0.83
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	57.21	13.40	0.00	1.40	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	76.19	16.06	0.94	1.10	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	50.01	6.99	0.00	1.61	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	69.02	20.17	1.89	0.95	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	57.36	13.69	0.22	0.54	0.75
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	35.29	6.16	0.00	0.82	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	35.14	15.17	0.00	1.01	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	54.19	13.51	0.84	1.55	1.13
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	36.39	6.72	1.58	0.40	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	46.73	14.74	0.39	0.19	0.78
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	44.25	13.33	0.19	0.74	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	50.17	6.97	1.05	0.70	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	53.91	12.88	0.48	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	53.84	13.60	0.14	0.82	0.96
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	45.89	5.54	0.92	0.92	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	42.40	11.22	0.31	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	63.50	13.54	0.37	0.73	0.91
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	56.94	10.20	0.33	0.66	1.32
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	49.20	16.40	0.88	0.29	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	50.78	11.95	0.25	0.75	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	39.28	5.82	1.45	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	32.58	10.50	0.54	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	65.24	16.50	0.00	1.06	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	47.18	5.70	0.52	1.04	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	36.02	13.40	0.21	0.42	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	64.51	12.33	0.45	0.90	0.90
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	42.65	5.50	2.06	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	33.49	13.17	0.56	0.38	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	55.03	13.25	0.21	0.42	0.95
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	42.16	7.75	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	30.76	7.28	0.33	0.66	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	55.13	12.88	0.87	1.49	1.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	67.01	12.59	1.11	1.85	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	23.23	9.39	0.49	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	47.16	13.47	0.14	1.10	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	48.57	7.08	0.32	1.29	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	42.30	9.43	0.00	0.91	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	55.29	15.54	0.56	0.70	0.70
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	46.58	6.40	0.00	0.71	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	26.66	10.67	0.48	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	56.49	12.92	0.16	1.71	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	36.88	7.88	1.07	1.07	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	27.77	8.82	0.65	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	44.02	16.24	0.47	0.94	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	85.39	6.31	1.11	1.49	1.11
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	21.77	7.43	0.51	0.26	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	55.49	6.86	0.30	0.90	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	49.85	4.53	6.80	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	83.62	11.51	1.53	3.07	3.07
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	48.24	5.94	1.48	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	108.74	18.19	2.12	2.96	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	77.37	11.96	2.11	3.52	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	50.43	3.74	3.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	81.93	12.37	2.06	2.58	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	59.47	9.52	2.38	3.57	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	84.14	12.44	0.90	1.81	1.13
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	123.31	18.32	2.04	2.91	2.04
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	69.78	13.96	1.80	2.25	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	116.52	12.87	2.98	0.68	1.08
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	130.95	14.89	2.05	2.57	1.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	86.45	8.82	1.41	2.12	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	61.30	2.00	0.67	2.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	125.82	15.79	1.53	4.08	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	86.71	10.41	0.80	0.53	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	82.95	15.49	1.13	3.02	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	117.19	11.04	4.91	4.91	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	111.71	12.23	4.89	2.45	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	83.51	14.79	1.67	2.29	2.08
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	135.09	14.85	1.12	3.64	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	84.49	6.18	2.06	2.06	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	91.16	19.45	1.16	4.06	1.45
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	107.61	11.06	1.49	1.49	1.79
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	71.37	8.30	1.66	1.66	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	110.99	19.44	1.77	3.53	2.83
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	120.22	14.38	0.00	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	65.62	8.06	2.30	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	65.24	17.27	0.38	4.22	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	101.34	16.98	1.13	2.26	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	68.10	7.38	0.82	2.46	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	70.95	14.01	0.90	3.16	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	109.16	12.21	2.87	1.44	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	73.20	16.43	0.00	2.99	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	79.15	11.89	0.74	5.95	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	104.67	7.75	0.43	2.15	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	95.91	8.56	1.71	0.00	3.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	78.63	12.66	1.33	4.33	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	107.39	13.88	3.62	2.41	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	61.15	7.82	2.13	2.84	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	90.05	15.81	1.72	2.41	1.72
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	73.00	9.12	1.07	2.15	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	71.38	8.75	1.35	0.00	2.02
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	101.86	17.04	0.37	2.22	2.59
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	41.87	4.65	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	48.66	13.75	0.00	4.23	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	85.23	15.61	2.40	1.20	1.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	93.04	10.18	0.00	0.73	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	88.15	9.96	2.30	3.07	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	80.40	22.20	1.48	1.48	2.47
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	84.68	16.94	0.94	4.70	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	85.48	9.05	1.01	0.50	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	77.96	16.67	1.80	4.51	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	94.66	3.44	1.72	5.16	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	88.62	14.70	1.78	1.78	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	80.16	17.60	3.13	2.74	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	86.43	7.26	1.32	3.96	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	71.61	7.78	2.08	3.11	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	71.76	24.07	2.63	2.63	2.63
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	94.49	10.06	1.12	2.80	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	81.26	10.60	3.09	1.77	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	73.67	15.81	2.70	3.47	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	89.12	9.62	1.52	3.04	2.53
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	94.68	6.73	0.48	1.44	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	81.10	16.70	0.80	2.39	1.59
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	112.41	9.72	0.61	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	67.10	11.76	3.46	1.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	78.66	12.54	2.66	3.04	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	82.63	14.98	1.55	2.58	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	45.95	12.09	2.42	0.60	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	73.52	15.53	0.63	2.54	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	83.16	9.60	1.07	1.07	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	39.08	11.49	1.15	1.72	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	78.16	13.88	1.03	2.06	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	74.98	10.61	1.41	2.83	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	49.37	13.05	1.70	1.13	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	82.37	12.48	0.83	1.66	1.66
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	78.30	8.61	1.57	1.57	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	34.24	15.45	0.42	1.25	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	52.97	10.69	0.93	4.65	1.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	83.63	10.04	0.67	1.34	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	35.29	17.11	0.53	2.14	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	60.21	14.95	0.81	2.83	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	65.16	11.01	0.92	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	44.46	15.11	1.78	3.56	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	69.52	14.25	0.57	1.14	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	64.42	8.44	0.77	1.53	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	71.13	16.96	0.55	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	57.91	11.58	0.89	2.67	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	91.50	13.26	1.82	2.60	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	59.02	13.93	1.33	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	130.95	12.47	0.00	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	81.59	10.71	0.46	0.23	0.23
Macrophage - monocyte derived, donor2	11313-117C8	103.68	6.61	0.73	0.37	0.55
Macrophage - monocyte derived, donor3	11389-118C3	93.72	6.29	0.52	1.18	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	46.73	5.31	0.53	2.12	0.00
Mallassez-derived cells, donor2	11929-125I3	90.16	5.39	0.95	0.95	0.79
Mallassez-derived cells, donor3	11930-125I4	96.60	5.70	1.11	0.56	0.28
Mammary Epithelial Cell, donor1	11273-116H4	165.71	19.63	1.40	0.90	0.80
Mammary Epithelial Cell, donor2	11350-117G9	111.77	8.98	0.29	2.61	1.45
Mammary Epithelial Cell, donor3	11422-118F9	87.30	8.48	0.75	0.75	0.50
Mast cell - stimulated, donor1	11487-119E2	195.25	26.44	3.39	0.68	0.68
Mast cell, donor1	11563-120D6	311.99	34.39	1.41	0.76	0.22
Mast cell, donor2	11565-120D8	661.51	125.11	0.30	1.49	0.59
Mast cell, donor3	11566-120D9	932.02	99.73	1.13	1.13	0.23
Mast cell, donor4	11567-120E1	1223.12	156.19	1.24	0.89	0.71
Mast cell, expanded and stimulated, donor5	11940-126A5	306.29	29.05	1.00	0.33	1.00
Mast cell, expanded and stimulated, donor8	11942-126A7	373.56	36.19	0.58	2.33	1.17
Mast cell, expanded, donor5	11939-126A4	253.99	35.68	1.26	2.18	1.03
Mast cell, expanded, donor8	11941-126A6	480.18	86.19	2.34	1.51	0.33
Melanocyte - dark, donor1	11502-119F8	70.25	11.64	2.39	1.59	0.70
Melanocyte - dark, donor2	11582-120F7	77.87	13.15	1.38	2.08	1.04
Melanocyte - dark, donor3	11663-122F7	75.63	11.30	1.23	0.51	0.14
Melanocyte - light, donor1	11274-116H5	77.34	9.40	1.65	0.00	0.47
Melanocyte - light, donor2	11351-117H1	48.46	10.92	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	93.66	13.01	0.87	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	69.14	7.91	0.52	0.94	0.62
Melanocyte, donor2 (MC+2)	12739-135I3	71.81	20.71	0.54	0.81	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	106.87	9.11	2.68	1.61	0.80
Meningeal Cells, donor1	11493-119E8	62.77	11.54	1.98	0.62	0.00
Meningeal Cells, donor2	11573-120E7	74.83	8.80	2.64	1.32	0.00
Meningeal Cells, donor3	11654-122E7	137.33	14.83	1.63	1.71	0.57
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	103.51	17.39	1.43	1.14	1.71
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	117.34	15.20	0.60	1.41	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	36.80	6.57	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	52.33	5.23	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	48.08	8.61	0.00	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	88.10	7.84	1.91	0.21	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	96.01	12.57	0.50	2.01	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	66.15	4.83	1.10	1.32	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	77.44	10.23	0.73	0.73	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	57.49	9.62	0.82	0.41	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	39.34	8.45	0.83	1.39	0.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	71.00	7.43	1.12	0.74	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	185.13	25.53	2.50	4.74	2.63
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	91.99	5.93	0.89	0.59	0.89
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	112.11	9.34	0.00	7.01	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	103.10	5.76	1.92	2.56	1.92
Mesenchymal stem cells - adipose, donor0	11217-116B2	57.42	10.28	0.35	0.71	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	124.15	19.08	1.56	2.50	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	38.46	2.90	0.73	2.18	0.00
Mesothelial Cells, donor1	11247-116E5	103.68	15.11	2.39	1.33	0.53
Mesothelial Cells, donor2	12156-128G5	57.55	6.51	0.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	96.55	11.63	0.72	1.59	0.58
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	124.23	14.85	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	122.40	9.60	0.25	0.49	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	70.67	17.37	0.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	10.37	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	67.57	8.06	0.93	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	62.44	14.73	0.00	0.41	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	27.79	6.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	108.36	13.01	0.00	1.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	64.70	20.48	0.93	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	87.99	11.38	0.61	0.61	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	60.58	15.84	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	34.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	67.26	9.73	0.88	0.88	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	61.93	16.72	0.38	1.14	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	23.69	3.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	68.76	14.01	0.42	0.42	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	22.10	4.60	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	74.51	7.15	0.00	1.19	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	20.12	8.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	33.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	66.99	10.04	0.75	1.76	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	55.14	15.45	0.48	0.71	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	34.83	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	89.57	5.30	0.00	1.15	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	47.75	16.62	0.63	0.42	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	71.34	7.13	0.82	0.82	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	82.60	3.86	0.43	1.50	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	48.01	14.89	0.67	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	64.39	4.38	0.00	0.66	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	37.51	11.15	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	33.14	6.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	80.99	4.89	0.54	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	49.11	10.29	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	34.89	5.45	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	65.84	8.65	0.48	1.44	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	56.03	10.41	0.40	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	87.76	6.86	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	54.06	5.51	0.00	2.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	20.39	4.08	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	54.30	3.50	0.00	1.31	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	32.01	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	28.82	3.20	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	59.50	5.21	0.50	0.99	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	30.62	2.78	2.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	28.73	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	57.09	2.74	0.34	0.00	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	32.38	3.50	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	60.37	4.97	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	40.40	2.24	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	29.09	1.66	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	23.31	1.75	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	46.76	3.92	0.30	0.90	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	43.83	3.34	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	43.31	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	55.41	2.77	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	60.90	3.98	0.00	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	60.25	5.11	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	42.50	3.89	0.26	1.30	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	45.47	6.86	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	24.77	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	41.10	3.20	0.00	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	73.93	4.49	0.60	0.60	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	52.26	3.81	0.71	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	44.27	2.23	0.32	0.96	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	49.98	4.42	0.44	0.66	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	29.96	3.79	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	57.67	4.26	1.14	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	49.41	6.64	0.49	0.74	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	72.34	4.56	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	78.80	4.12	0.59	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	71.79	4.90	0.58	0.58	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	210.19	6.59	0.82	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	46.75	2.68	1.19	0.60	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	22.60	7.53	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	76.64	10.69	0.00	3.56	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	115.66	10.19	1.31	0.66	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	98.88	12.62	0.00	6.31	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	131.66	9.29	0.40	1.78	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	87.54	13.04	0.00	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	134.81	16.15	0.38	2.63	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	100.14	14.12	0.80	1.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	57.00	3.85	0.45	1.36	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	100.93	12.52	0.74	0.74	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	102.97	4.03	1.10	2.93	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	80.89	10.89	0.00	9.33	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	33.67	0.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	42.50	0.00	0.00	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	97.96	10.10	1.01	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	53.55	4.64	0.00	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	8.17	0.00	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	11.44	0.64	0.00	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	18.63	0.00	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	45.31	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	17.13	0.00	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	19.57	0.00	3.26	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	4.75	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	62.75	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	83.16	6.68	0.86	0.86	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	228.38	30.31	1.05	0.52	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	323.73	7.34	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	171.54	12.94	1.25	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	247.75	25.86	1.33	0.95	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	298.42	15.96	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	238.66	8.16	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	73.51	33.08	0.00	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	268.70	15.49	0.84	0.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	194.78	10.46	0.00	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	316.71	24.05	1.89	0.81	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	248.08	24.18	1.26	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	155.89	55.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	239.24	7.45	0.50	0.50	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	169.98	28.15	0.27	0.54	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	184.52	8.61	1.13	1.36	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	224.54	21.39	1.63	0.16	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	212.51	12.94	1.46	0.55	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	327.28	13.79	2.65	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	312.16	12.61	1.20	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	306.85	51.85	3.28	0.66	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	193.20	12.36	0.98	0.65	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	329.13	15.35	1.23	0.18	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	234.18	7.74	1.41	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	283.18	15.63	1.38	0.46	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	227.51	13.50	0.32	0.96	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	184.17	40.01	2.07	0.69	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	189.63	83.44	0.00	5.06	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	278.26	17.82	1.34	0.22	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	233.71	12.70	1.27	0.42	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	242.10	19.23	0.71	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	269.57	16.74	0.43	1.72	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	108.33	9.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	227.26	9.33	0.00	1.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	314.70	26.15	0.90	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	179.75	7.94	0.00	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	239.59	17.64	0.00	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	183.89	14.00	0.76	1.51	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	204.98	11.73	0.98	0.65	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	317.69	12.64	0.87	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	318.86	14.93	1.36	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	312.20	6.17	0.00	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	325.77	15.96	0.00	1.33	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	272.82	15.87	1.49	1.49	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	338.42	9.57	1.53	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	164.23	12.70	0.30	0.30	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	179.47	16.58	1.11	0.66	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	310.37	7.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	81.75	35.77	5.11	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	251.80	10.36	1.22	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	270.36	11.96	0.63	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	480.92	23.00	1.51	0.61	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	401.90	16.61	0.79	0.79	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	293.61	58.95	0.00	1.13	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	96.10	40.46	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	45.47	7.58	0.75	0.99	0.50
Myoblast, donor2	11322-117D8	80.93	14.77	1.73	2.11	1.73
Myoblast, donor3	11398-118D3	84.92	7.23	2.02	0.00	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	138.49	4.09	0.58	0.44	0.44
Natural Killer Cells, donor1	11230-116C6	202.65	30.14	0.92	0.92	0.31
Natural Killer Cells, donor2	11311-117C6	248.18	35.89	0.30	3.02	0.60
Natural Killer Cells, donor3	11387-118C1	266.33	14.17	1.84	1.84	1.10
Neural stem cells, donor1	11275-116H6	229.02	40.65	6.90	2.90	0.00
Neural stem cells, donor2	11352-117H2	433.27	53.92	5.78	1.93	0.00
Neurons, donor1	11494-119E9	283.34	36.41	2.28	11.38	6.83
Neurons, donor2	11574-120E8	346.32	53.72	2.86	6.16	2.64
Neurons, donor3	11655-122E8	764.61	50.97	2.47	9.87	6.58
Neutrophils, donor1	11233-116C9	598.56	85.38	0.93	1.86	0.93
Neutrophils, donor2	11314-117C9	518.90	124.65	2.90	20.29	8.70
Neutrophils, donor3	11390-118C4	773.94	112.40	1.22	1.22	1.83
Nucleus Pulposus Cell, donor1	11252-116F1	225.95	26.60	1.66	3.80	2.85
Nucleus Pulposus Cell, donor2	11409-118E5	172.57	6.51	1.30	2.93	1.63
Nucleus Pulposus Cell, donor3	11462-119B4	86.04	14.84	0.60	2.41	0.40
Olfactory epithelial cells, donor1	11933-125I7	371.80	22.16	1.24	1.24	0.96
Olfactory epithelial cells, donor2	11934-125I8	266.62	14.62	0.43	3.47	2.17
Olfactory epithelial cells, donor3	11935-125I9	268.78	15.44	0.45	1.82	1.48
Olfactory epithelial cells, donor4	11936-126A1	455.23	26.01	1.27	0.68	1.07
Oligodendrocyte - precursors, donor1	11496-119F2	108.93	15.05	1.20	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	237.37	13.19	1.06	0.85	0.21
Osteoblast - differentiated, donor2	11353-117H3	40.01	19.43	0.00	1.14	1.14
Osteoblast - differentiated, donor3	11425-118G3	62.69	14.90	0.62	1.86	1.86
Osteoblast, donor1	11277-116H8	147.55	18.37	2.54	1.17	1.37
Osteoblast, donor2	11354-117H4	77.25	3.51	2.81	1.40	1.40
Osteoblast, donor3	11426-118G4	73.40	9.42	1.07	0.89	0.18
Pancreatic stromal cells, donor1	11249-116E7	101.17	10.87	1.43	1.10	0.76
Pericytes, donor1	11491-119E6	69.99	12.46	1.34	0.67	0.45
Pericytes, donor2	11571-120E5	79.00	10.64	1.13	0.23	0.23
Pericytes, donor3	11652-122E5	89.31	15.06	1.02	1.42	1.02
Perineurial Cells, donor1	11499-119F5	138.23	15.82	1.24	2.83	1.02
Perineurial Cells, donor2	11579-120F4	138.75	14.17	2.21	1.47	1.66
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	222.80	28.37	2.23	2.23	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	224.29	26.93	0.98	2.45	1.47
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	227.51	10.87	0.52	1.55	1.29
Placental Epithelial Cells, donor1	11278-116H9	68.64	5.26	0.24	0.24	0.00
Placental Epithelial Cells, donor2	11355-117H5	54.34	7.76	4.44	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	57.33	9.23	1.18	1.77	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	80.06	8.86	0.00	1.27	0.63
Preadipocyte - breast, donor1	11467-119B9	102.05	14.82	0.94	1.13	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	29.50	3.13	0.26	0.13	0.00
Preadipocyte - breast, donor2	11328-117E5	74.97	17.34	0.45	3.60	1.35
Preadipocyte - omental, donor1	11468-119C1	193.08	26.96	0.75	1.39	0.21
Preadipocyte - omental, donor2	11329-117E6	127.01	5.24	0.44	2.18	0.00
Preadipocyte - omental, donor3	11403-118D8	130.36	6.73	0.29	0.57	0.43
Preadipocyte - perirenal, donor1	11469-119C2	57.09	5.91	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	51.29	7.37	0.92	0.00	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	60.91	12.40	0.18	2.12	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	69.99	9.88	1.87	2.04	1.19
Preadipocyte - visceral, donor1	11280-116I2	92.77	10.34	0.56	0.28	0.28
Preadipocyte - visceral, donor2	11357-117H7	81.91	14.27	1.38	1.38	1.38
Preadipocyte - visceral, donor3	11429-118G7	43.47	6.69	0.42	1.36	0.63
Prostate Epithelial Cells (polarized), donor1	11253-116F2	94.74	13.58	1.51	0.60	0.91
Prostate Epithelial Cells, donor2	11331-117E8	66.35	15.44	0.68	1.08	0.27
Prostate Epithelial Cells, donor3	11404-118D9	198.65	15.80	0.24	1.29	1.16
Prostate Stromal Cells, donor1	11254-116F3	76.31	7.75	0.23	1.82	0.34
Prostate Stromal Cells, donor2	11332-117E9	84.63	15.78	0.18	2.87	1.08
Prostate Stromal Cells, donor3	11405-118E1	113.14	9.91	1.67	2.09	1.04
Renal Cortical Epithelial Cells, donor1	11516-119H4	114.24	13.14	0.36	0.73	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	155.19	16.43	1.18	2.84	1.80
Renal Epithelial Cells, donor1	11517-119H5	75.07	9.13	0.51	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	106.70	12.80	0.71	0.00	1.42
Renal Epithelial Cells, donor3	11678-122H4	188.33	21.91	1.38	2.86	2.01
Renal Glomerular Endothelial Cells, donor1	11514-119H2	52.43	6.13	0.00	0.68	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	66.71	7.14	0.27	0.67	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	119.44	10.43	0.67	0.44	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	45.25	7.32	0.00	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	101.46	10.34	1.54	0.22	0.22
Renal Mesangial Cells, donor2	11598-120H5	146.71	16.93	3.13	0.63	1.25
Renal Mesangial Cells, donor3	11679-122H5	75.73	17.75	0.00	0.83	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	90.73	7.52	2.15	0.54	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	99.94	8.01	0.84	0.00	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	97.97	21.79	1.54	1.54	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	101.12	18.15	1.81	1.56	1.30
Retinal Pigment Epithelial Cells, donor1	11528-119I7	138.43	12.51	3.41	0.85	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	54.54	13.38	0.00	1.03	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	165.10	18.57	2.76	1.51	1.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	320.99	30.20	1.74	0.94	0.80
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	99.17	2.68	1.79	0.89	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	288.94	12.11	3.30	1.10	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	290.03	6.96	2.90	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	88.55	10.01	1.69	0.78	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	121.65	15.29	1.59	1.69	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	98.82	12.16	1.00	1.45	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	47.51	19.72	1.24	1.86	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	112.82	19.70	1.86	1.28	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	109.33	18.03	1.62	2.31	0.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	65.72	12.46	1.37	0.14	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	106.19	18.46	0.91	0.91	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	90.13	11.47	1.79	0.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	65.13	11.48	1.00	0.29	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	100.77	12.77	1.72	1.18	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	107.09	15.49	1.77	1.11	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	51.81	8.22	1.15	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	136.67	13.97	1.02	1.30	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	135.48	11.09	3.01	1.13	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	91.17	9.69	1.86	0.53	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	120.02	12.65	1.85	0.49	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	112.28	14.51	1.91	0.76	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	72.51	9.08	1.92	0.53	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	105.68	14.58	2.24	1.68	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	81.69	15.89	1.54	0.85	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	80.04	12.58	1.28	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	118.34	12.51	2.58	1.10	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	87.04	14.10	1.75	1.75	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	36.32	6.60	0.71	0.47	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	137.90	15.28	1.59	1.19	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	110.84	12.63	3.04	1.40	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	58.47	12.23	1.45	0.00	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	117.02	13.05	1.11	2.65	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	127.63	10.24	1.67	0.21	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	72.68	11.71	0.94	0.54	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	147.82	13.96	2.38	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	130.33	17.16	1.93	1.16	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	47.28	12.72	1.38	0.52	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	137.03	13.85	1.78	0.69	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	119.35	13.13	2.79	0.99	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	59.99	7.16	2.39	0.51	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	107.42	18.35	1.63	2.07	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	139.41	9.60	2.67	1.33	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	74.94	9.96	0.97	0.97	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	84.53	15.71	1.19	0.95	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	182.80	13.30	2.62	0.60	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	69.50	10.36	1.13	0.94	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	114.59	17.47	1.05	0.70	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	126.93	10.88	1.21	1.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	104.15	15.30	2.08	0.24	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	129.40	16.45	1.31	1.16	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	106.47	12.17	1.22	1.22	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	79.57	13.56	0.90	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	156.52	25.33	1.13	0.90	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	131.80	12.88	0.90	1.50	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	98.83	19.36	1.42	1.18	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	159.66	28.39	0.85	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	135.82	12.62	0.60	0.60	0.60
Schwann Cells, donor1	11498-119F4	70.15	6.21	0.75	1.69	0.00
Schwann Cells, donor2	11578-120F3	37.43	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	81.06	11.17	0.88	2.19	0.44
Sebocyte, donor1	11220-116B5	248.69	23.55	1.64	0.55	0.00
Sebocyte, donor2	11301-117B5	149.36	28.03	3.22	2.76	0.46
Sebocyte, donor3	11378-118B1	128.41	11.34	1.65	2.06	0.41
Sertoli Cells, donor1	11255-116F4	185.54	19.88	1.66	4.97	0.00
Sertoli Cells, donor2	11333-117F1	194.88	22.59	0.00	8.47	0.00
Skeletal Muscle Cells, donor1	11281-116I3	264.90	31.94	1.06	1.85	1.32
Skeletal Muscle Cells, donor2	11358-117H8	73.01	18.79	0.72	0.72	0.72
Skeletal Muscle Cells, donor3	11430-118G8	50.16	16.72	1.67	1.67	0.00
Skeletal Muscle Cells, donor4	11451-119A2	64.57	9.27	0.63	1.26	0.47
Skeletal Muscle Cells, donor5	11455-119A6	70.61	11.00	0.45	2.23	0.89
Skeletal Muscle Cells, donor6	11459-119B1	66.49	10.16	0.15	1.85	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	176.53	22.56	1.01	2.39	1.64
Skeletal Muscle Satellite Cells, donor2	11321-117D7	113.72	23.69	1.28	3.00	1.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	109.33	10.22	0.99	1.59	0.50
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	181.14	22.75	2.19	1.43	0.67
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	83.23	10.86	1.45	1.45	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	83.25	8.94	0.83	0.69	0.28
Skin - palm, donor1	10286-104F7	174.60	10.74	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	66.31	3.89	1.59	0.58	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	28.63	0.82	2.45	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	112.43	6.10	1.82	2.21	0.91
Small Airway Epithelial Cells, donor1	11256-116F5	169.87	16.54	0.83	1.53	1.11
Small Airway Epithelial Cells, donor2	11334-117F2	236.16	19.97	0.84	0.84	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	72.95	11.21	2.75	0.00	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	252.13	16.56	1.42	1.35	0.75
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	32.40	13.27	0.31	2.16	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	9.12	2.67	0.00	0.00	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	96.99	10.58	1.18	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	97.46	11.93	1.10	0.44	0.88
Smooth Muscle Cells - Aortic, donor2	11360-117I1	51.59	3.15	0.79	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	112.79	7.73	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	202.15	19.01	2.00	5.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	127.09	18.50	0.67	0.40	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	89.99	9.53	0.44	1.55	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	24.71	4.35	0.26	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	71.63	12.37	1.30	0.00	0.98
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	104.25	6.20	1.18	0.59	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	62.36	2.14	0.85	0.71	0.85
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	47.34	4.39	0.00	0.33	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	157.09	15.83	1.22	0.30	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	146.99	21.72	4.04	0.51	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	250.95	6.12	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	72.96	15.74	0.00	1.43	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	69.46	10.18	0.88	0.59	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	70.60	11.41	1.08	0.65	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	85.96	5.35	0.52	1.36	0.73
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	101.62	7.12	0.77	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	32.34	8.62	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	35.27	5.38	0.60	0.60	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	57.36	8.53	0.68	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	195.69	19.16	0.63	4.48	2.83
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	135.06	23.55	1.61	0.40	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	51.43	8.19	0.46	2.28	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	47.10	12.08	0.00	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	89.81	10.07	0.53	3.18	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	108.92	15.05	0.53	0.67	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	116.08	14.53	1.00	0.88	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	101.72	12.43	0.51	3.30	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	103.88	11.91	1.06	1.66	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	51.01	6.00	0.00	0.00	2.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	532.39	67.20	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	125.10	10.70	0.47	1.86	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	64.12	15.15	0.00	1.51	1.51
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	63.93	11.28	0.63	0.63	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	42.48	3.24	0.29	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	58.48	6.58	1.08	0.33	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	120.53	13.55	0.93	0.00	1.87
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	97.14	8.78	0.43	0.00	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	83.12	7.14	0.00	1.53	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	75.78	8.09	0.38	0.38	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	90.00	11.88	1.26	2.24	0.70
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	78.17	10.64	1.17	0.84	0.67
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	58.57	5.71	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	71.93	7.83	0.24	0.49	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	153.34	17.90	0.22	0.44	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	99.77	3.22	0.59	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	240.42	7.97	0.39	0.78	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	58.44	2.12	0.26	1.85	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	176.67	7.44	2.23	1.49	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	109.24	2.87	0.72	1.08	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	54.51	2.27	0.28	1.99	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	124.07	2.36	1.58	1.58	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	125.96	8.89	0.00	3.56	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	306.28	17.17	1.20	1.60	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	178.91	11.70	0.42	4.18	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	170.05	8.71	0.46	2.29	0.46
Synoviocyte, donor1	11291-117A4	90.89	20.03	0.34	1.35	0.34
Synoviocyte, donor2	11368-117I9	130.41	9.55	1.68	1.17	1.34
Synoviocyte, donor3	11440-118H9	94.95	14.52	0.22	2.01	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	105.41	4.65	1.07	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	107.03	5.95	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	82.89	15.28	1.16	1.39	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	209.46	20.57	0.86	0.50	0.57
Tracheal Epithelial Cells, donor2	11369-118A1	88.91	6.57	0.00	1.16	1.16
Tracheal Epithelial Cells, donor3	11441-118I1	73.30	14.32	0.00	2.29	1.72
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	348.40	31.13	1.60	2.21	1.23
Urethra, donor2	10319-105A4	579.09	32.37	7.19	1.80	0.00
Urothelial Cells, donor1	11520-119H8	101.48	6.11	1.59	0.80	0.00
Urothelial Cells, donor2	11600-120H7	92.13	6.01	0.40	2.00	1.20
Urothelial Cells, donor3	11681-122H7	86.18	16.50	0.92	1.60	0.92
Urothelial cells, donor0	11216-116B1	187.68	24.74	0.67	2.45	1.34
Whole blood (ribopure), donor090309, donation1	12179-129A1	694.92	176.18	2.67	6.23	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	777.71	190.14	0.00	5.72	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	1084.28	171.13	0.68	9.58	4.79
Whole blood (ribopure), donor090325, donation1	12176-128I7	1041.62	113.29	0.00	4.82	3.79
Whole blood (ribopure), donor090325, donation2	12177-128I8	986.58	116.21	1.74	6.97	3.49
Whole blood (ribopure), donor090612, donation1	12182-129A4	507.08	127.03	2.08	2.08	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	560.77	132.16	0.00	8.26	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	1200.46	206.32	0.00	9.13	3.65
Wilms' tumor cell line:G-401	10809-111A8	157.29	3.33	1.85	0.62	0.86
Wilms' tumor cell line:HFWT	10597-108E3	196.25	13.20	0.88	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	177.93	8.94	2.79	0.56	0.00
achilles tendon, donor2	10292-104G4	241.78	35.13	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	253.43	24.48	3.06	0.76	1.02
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	189.69	16.02	1.16	1.16	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	310.42	38.58	3.92	0.59	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	196.74	13.61	3.27	1.90	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	64.93	10.96	0.84	0.28	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	107.43	19.67	0.85	2.75	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	272.76	37.57	0.27	4.63	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	180.22	18.07	0.44	0.88	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	188.66	21.23	0.82	2.04	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	265.98	7.77	0.00	0.78	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	94.39	16.01	0.55	0.37	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	171.62	19.50	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	136.87	10.69	0.70	1.16	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	229.39	30.29	5.95	2.59	2.33
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	205.45	28.64	4.68	4.09	1.17
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	124.56	13.48	1.86	0.93	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	132.42	14.81	0.00	2.47	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	294.98	10.13	0.92	0.31	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	168.55	11.09	2.56	0.85	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	143.46	12.13	0.61	0.91	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	147.31	12.76	1.68	0.72	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	88.43	10.91	0.45	1.56	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	102.40	13.01	0.67	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	165.38	13.01	3.72	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	103.96	13.18	1.88	1.88	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	162.68	23.12	1.74	0.87	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	91.85	5.62	1.87	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	300.03	2.83	0.47	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	315.67	38.16	1.09	1.55	0.93
adipose, donor1	10184-103D4	469.71	101.45	36.94	3.52	0.59
adipose, donor2	10185-103D5	816.71	74.62	4.87	1.22	0.00
adipose, donor3	10186-103D6	602.57	46.83	3.81	0.82	0.54
adipose, donor4	10187-103D7	683.00	38.14	7.80	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	152.77	1.89	2.05	0.95	0.63
adrenal gland, adult, pool1	10081-102A9	160.06	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	69.10	8.54	0.40	0.13	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	134.34	8.22	0.36	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	144.21	16.00	0.46	2.32	0.23
amniotic membrane cells, donor2	12236-129G4	159.58	26.37	0.68	3.72	0.00
amniotic membrane cells, donor3	12237-129G5	76.30	27.99	0.59	0.59	0.59
amygdala - adult, donor10196	10167-103B5	179.06	9.49	3.56	2.37	1.19
amygdala, adult, donor10252	10151-102I7	229.13	17.24	2.64	1.01	1.01
amygdala, newborn, donor10223	10360-105E9	155.25	10.01	2.58	0.00	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	198.63	36.16	0.76	2.16	1.15
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	144.07	2.65	0.22	1.10	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	214.45	7.68	2.34	0.33	0.00
aorta, adult, pool1	10052-101G7	582.52	17.65	0.59	5.69	2.94
appendix, adult	10189-103D9	470.01	43.86	0.78	0.39	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	216.34	14.79	13.76	1.03	0.34
artery, adult	10190-103E1	232.34	33.97	2.72	2.72	1.36
astrocytoma cell line:TM-31	10425-106D2	194.41	18.69	1.74	1.30	0.29
b cell line:RPMI1788	10427-106D4	103.35	14.57	0.74	0.45	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	128.18	9.16	0.28	0.83	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	105.58	9.82	0.89	0.20	0.60
bile duct carcinoma cell line:TFK-1	10496-107C1	102.60	8.03	0.17	0.17	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	247.18	28.52	0.56	1.12	0.56
bladder, adult, pool1	10011-101C2	584.05	55.84	0.54	2.72	1.09
blood, adult, pool1	10053-101G8	1979.88	79.73	0.00	2.21	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	141.30	10.28	1.71	0.00	0.00
bone marrow, adult	10192-103E3	184.90	30.37	2.02	4.05	0.00
brain, adult, donor1	10084-102B3	685.77	24.60	4.10	5.13	2.05
brain, adult, pool1	10012-101C3	464.59	55.79	4.57	1.78	1.78
brain, fetal, pool1	10085-102B4	1055.20	29.39	8.01	2.67	2.67
breast carcinoma cell line:MCF7	10482-107A5	383.88	30.39	0.99	1.32	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	349.13	29.08	5.37	1.37	0.37
breast, adult, donor1	10080-102A8	729.22	36.62	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	172.64	3.68	0.64	0.51	1.02
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	252.01	17.01	0.31	0.31	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	110.04	19.80	0.92	4.14	2.07
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	139.68	10.41	0.97	0.24	0.48
carcinoid cell line:NCI-H1770	10703-109H1	260.94	37.61	1.41	0.47	1.41
carcinoid cell line:NCI-H727	10735-110B6	185.07	11.27	2.30	0.55	0.66
carcinoid cell line:SK-PN-DW	10719-109I8	239.89	19.01	1.58	0.95	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	253.14	9.05	3.73	2.13	1.06
caudate nucleus - adult, donor10196	10177-103C6	337.34	19.57	10.36	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	154.94	14.39	2.01	2.68	1.17
caudate nucleus, adult, donor10258	10379-105H1	320.17	14.52	0.76	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	294.09	12.82	3.66	1.46	0.37
cerebellum - adult, donor10196	10173-103C2	1104.13	46.61	5.83	5.83	0.00
cerebellum, adult, donor10252	10166-103B4	699.67	62.13	4.27	3.84	1.92
cerebellum, adult, pool1	10083-102B2	620.21	23.46	3.79	5.52	4.14
cerebellum, newborn, donor10223	10357-105E6	539.69	20.76	10.79	0.83	0.83
cerebral meninges, adult	10188-103D8	335.09	36.81	1.51	0.50	0.50
cerebrospinal fluid, donor2	10294-104G6	318.67	19.00	0.00	1.46	0.00
cervical cancer cell line:D98-AH2	10552-107I3	142.78	13.08	0.43	0.14	0.14
cervical cancer cell line:ME-180	10553-107I4	113.85	10.61	0.50	0.33	0.33
cervix, adult, pool1	10013-101C4	612.72	49.98	2.41	1.99	1.36
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	76.08	9.89	1.95	0.42	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	120.18	14.37	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	160.81	15.91	1.62	1.12	0.25
choriocarcinoma cell line:SCH	10785-110H2	102.76	2.83	2.83	0.86	0.86
choriocarcinoma cell line:T3M-3	10618-108G6	110.76	7.83	0.95	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	86.90	13.68	0.57	2.85	0.00
chorionic membrane cells, donor2	12239-129G7	122.70	19.29	1.09	2.19	0.40
chorionic membrane cells, donor3	12240-129G8	53.85	31.32	0.55	7.14	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	65.64	6.06	1.01	10.10	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	240.51	5.76	0.96	0.58	0.96
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	273.49	6.97	1.48	0.84	1.27
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	87.31	11.56	2.82	0.77	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	106.43	13.79	4.11	0.73	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	100.58	12.62	2.85	1.02	1.02
chronic myelogenous leukemia cell line:K562	10454-106G4	135.74	17.37	1.47	0.88	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	355.23	28.67	2.61	1.56	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	73.37	3.43	0.23	0.46	0.46
clear cell carcinoma cell line:TEN	10636-108I6	198.49	9.72	1.74	1.91	0.17
colon carcinoma cell line:CACO-2	10513-107D9	87.31	8.05	2.56	0.55	0.18
colon carcinoma cell line:COLO-320	10420-106C6	358.80	55.11	9.50	1.90	0.76
colon, adult, donor1	10082-102B1	334.40	11.90	1.19	1.19	2.38
colon, adult, pool1	10014-101C5	498.21	37.37	1.76	0.59	0.12
colon, fetal, donor1	10070-101I7	1175.41	36.46	0.00	1.24	1.24
common myeloid progenitor CMP, donor1	12130-128D6	114.59	27.50	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	182.30	19.55	3.40	0.42	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	174.48	18.56	1.36	0.60	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	151.73	20.31	1.41	0.56	0.42
corpus callosum, adult, pool1	10042-101F6	216.92	34.38	4.75	2.43	1.55
cruciate ligament, donor2	10295-104G7	372.01	25.12	0.00	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	333.87	5.62	0.80	4.01	1.61
diencephalon, adult	10193-103E4	220.31	18.00	1.68	0.72	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	152.69	5.28	1.15	2.76	2.07
ductal cell carcinoma cell line:KLM-1	10438-106E6	112.58	4.87	1.03	0.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	174.28	12.04	0.48	1.20	0.48
ductus deferens, adult	10196-103E7	275.58	51.83	2.99	1.99	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	557.37	5.76	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	241.29	18.39	3.68	2.94	1.47
dura mater, adult, donor1	10041-101F5	196.39	25.27	1.16	1.32	0.74
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	158.78	15.55	7.33	0.67	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	121.37	14.47	5.30	0.86	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	186.83	5.55	0.62	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	105.95	6.66	0.00	0.61	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	149.43	5.87	0.93	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	93.26	7.88	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	138.77	8.04	0.67	0.00	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	249.92	28.09	1.99	1.99	1.27
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	105.33	6.91	1.29	0.96	0.64
epidermoid carcinoma cell line:A431	10426-106D3	148.06	10.23	0.78	0.33	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	79.85	6.05	0.88	0.55	0.22
epididymis, adult	10197-103E8	375.09	48.56	3.56	1.47	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	100.24	7.81	0.35	0.18	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	87.69	5.90	0.79	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	64.21	9.04	1.57	1.70	0.92
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	66.93	8.76	1.48	0.69	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	61.17	7.51	1.12	1.01	1.46
esophagus, adult, pool1	10015-101C6	392.75	34.51	0.64	1.27	1.38
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	434.94	34.57	4.26	1.13	1.13
eye - muscle inferior rectus, donor1	10272-104E2	514.30	36.22	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	305.11	10.52	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	318.48	22.32	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	357.71	22.93	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	154.48	4.37	1.46	1.46	0.00
eye, fetal, donor1	10054-101G9	509.99	16.02	3.56	4.07	3.05
fibrosarcoma cell line:HT-1080	10758-110E2	185.28	3.72	0.64	0.77	0.64
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	146.01	12.58	0.71	0.24	1.19
frontal lobe, adult, pool1	10040-101F4	329.98	42.78	5.16	2.25	1.78
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	144.42	6.91	1.50	0.60	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	179.67	12.07	1.74	1.28	0.82
gall bladder, adult	10198-103E9	325.69	46.11	0.97	1.93	1.21
gamma delta positive T cells, donor1	11937-126A2	314.60	17.18	1.07	2.15	0.00
gamma delta positive T cells, donor2	11938-126A3	272.65	27.64	0.00	1.49	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	151.02	10.14	0.63	2.11	1.06
gastric adenocarcinoma cell line:MKN45	10612-108F9	59.77	3.87	0.19	0.58	0.39
gastric cancer cell line:AZ521	10549-107H9	159.36	12.30	2.30	0.16	0.49
gastric cancer cell line:GSS	10560-108A2	93.35	3.66	5.49	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	97.78	3.88	2.74	2.74	0.91
giant cell carcinoma cell line:LU65	10487-107B1	111.76	7.92	1.49	0.57	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	159.27	16.80	0.70	0.56	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	134.44	11.22	0.50	0.25	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	60.16	4.12	0.95	0.00	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	87.63	2.95	2.67	0.00	0.00
glioblastoma cell line:T98G	10485-107A8	123.62	9.05	1.43	0.22	0.00
glioma cell line:GI-1	10413-106B8	212.04	15.82	1.46	0.88	0.88
globus pallidus - adult, donor10196	10175-103C4	237.63	18.95	2.19	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	302.68	28.80	1.95	2.20	1.22
globus pallidus, adult, donor10258	10367-105F7	291.64	19.17	1.37	4.11	2.74
globus pallidus, newborn, donor10223	10364-105F4	233.42	12.79	2.13	2.66	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	90.54	17.13	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	15.68	0.00	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	216.64	11.52	0.64	0.64	0.00
hIPS +CCl2, biol_rep1	14383-156B9	81.26	0.00	6.43	1.38	0.92
hIPS +CCl2, biol_rep2	14384-156C1	27.89	0.46	5.49	0.91	0.46
hIPS +CCl2, biol_rep3	14385-156C2	47.02	1.29	9.02	1.29	0.00
hIPS, biol_rep1	14380-156B6	31.62	0.00	5.75	2.87	0.00
hIPS, biol_rep2	14381-156B7	47.32	0.00	2.74	1.37	0.00
hIPS, biol_rep3	14382-156B8	72.83	5.52	7.72	1.10	1.10
hairy cell leukemia cell line:Mo	10712-109I1	166.08	19.25	1.15	0.86	2.01
heart - mitral valve, adult	10205-103F7	214.36	32.89	1.20	2.69	1.49
heart - pulmonic valve, adult	10206-103F8	228.79	34.51	0.78	2.61	1.57
heart - tricuspid valve, adult	10207-103F9	347.21	43.30	0.83	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	307.51	8.37	0.41	1.22	0.41
heart, adult, diseased, donor1	10051-101G6	502.48	16.18	0.85	2.13	3.41
heart, adult, pool1	10016-101C7	562.52	41.40	1.15	0.46	0.23
heart, fetal, pool1	10046-101G1	429.00	38.92	3.39	2.36	1.44
hepatic mesenchymal tumor cell line:LI90	10778-110G4	405.71	7.10	0.93	0.62	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	145.08	1.19	3.57	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	84.86	7.62	4.31	1.22	0.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	76.95	7.04	2.79	1.21	0.49
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	85.69	9.09	3.23	1.11	0.81
hepatoma cell line:Li-7	10484-107A7	127.01	10.79	1.11	0.22	0.44
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	85.73	3.12	0.80	0.70	0.50
hippocampus - adult, donor10196	10169-103B7	210.08	10.41	3.79	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	281.66	24.49	3.06	3.06	2.25
hippocampus, adult, donor10258	10374-105G5	157.35	2.49	4.98	1.49	0.00
hippocampus, newborn, donor10223	10363-105F3	259.78	14.80	0.70	0.00	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	267.94	18.92	9.77	3.66	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	248.19	23.37	4.12	1.18	0.79
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	218.60	15.49	7.36	1.27	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	728.51	50.18	10.71	3.38	1.69
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	1112.63	147.70	11.36	8.52	4.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	543.60	47.07	20.12	4.18	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	408.44	38.25	7.88	1.46	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	560.33	71.95	7.54	1.29	1.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	445.43	38.79	5.42	1.25	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	219.03	26.05	6.87	2.13	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	483.92	52.88	7.55	1.29	1.93
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	255.18	39.72	4.04	3.37	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	220.49	25.19	5.63	1.10	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	219.12	14.25	3.44	2.95	2.46
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	268.81	17.46	6.98	4.36	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	1109.38	131.54	16.42	2.29	1.15
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	803.25	85.03	15.26	2.62	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	701.67	68.97	27.49	3.50	4.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	539.18	70.27	4.14	3.39	2.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	595.23	70.03	6.37	1.82	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	465.16	44.48	6.58	1.25	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	427.52	48.99	6.21	2.61	1.14
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	351.85	37.45	2.90	1.74	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	418.79	42.45	5.38	1.20	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	250.70	31.59	4.99	1.85	1.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	261.89	23.96	5.71	1.14	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	231.51	14.29	6.12	4.08	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	473.55	69.36	7.75	5.28	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	548.28	68.42	10.77	3.80	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	462.71	45.39	9.08	1.82	2.12
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	328.37	42.40	3.62	1.55	1.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	393.19	44.50	5.98	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	169.31	24.37	4.87	1.54	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	228.55	30.93	5.37	1.79	2.05
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	368.77	52.25	5.30	5.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	333.03	29.91	2.69	0.34	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	226.05	21.49	5.55	0.97	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	213.03	17.38	5.79	0.89	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	282.93	22.44	5.37	3.41	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	501.52	80.07	14.36	3.06	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	435.93	87.84	35.79	29.28	9.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	571.87	56.26	20.19	4.63	2.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	344.25	61.84	8.76	1.09	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	309.41	31.85	10.49	0.72	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	289.68	37.01	9.25	1.42	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	329.37	21.48	5.97	3.58	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	298.88	39.14	7.58	1.08	1.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	284.21	30.98	2.96	1.08	1.35
immature langerhans cells, donor1	11904-125F5	175.07	8.96	0.24	1.94	1.21
immature langerhans cells, donor2	11905-125F6	110.90	22.97	0.79	0.79	0.00
insula, adult, pool1	10039-101F3	293.74	38.99	5.68	1.42	0.66
keratoacanthoma cell line:HKA-1	10791-110H8	151.52	3.58	1.63	0.98	0.33
kidney, adult, pool1	10017-101C8	277.95	25.33	3.50	1.10	0.90
kidney, fetal, pool1	10045-101F9	301.26	25.68	2.83	2.12	0.92
large cell lung carcinoma cell line:IA-LM	10509-107D5	246.97	15.48	1.99	0.00	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	72.72	8.57	0.28	0.41	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	123.13	17.80	0.55	0.37	0.55
left atrium, adult, donor1	10079-102A7	682.15	29.42	1.63	0.54	0.00
left ventricle, adult, donor1	10078-102A6	656.85	25.28	0.51	2.02	0.00
leiomyoblastoma cell line:G-402	10721-110A1	201.10	3.01	2.19	0.55	0.00
leiomyoma cell line:10964C	10569-108B2	43.47	6.83	0.00	1.80	0.72
leiomyoma cell line:15242A	10570-108B3	38.59	3.26	0.00	0.54	0.00
leiomyoma cell line:15425	10571-108B4	61.92	3.89	1.46	0.73	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	38.10	12.70	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	174.61	4.18	3.14	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	120.54	5.31	0.12	0.47	0.24
liposarcoma cell line:KMLS-1	10782-110G8	124.03	3.91	1.09	0.78	0.47
liposarcoma cell line:SW 872	10726-110A6	168.75	6.21	1.34	0.37	0.12
liver, adult, pool1	10018-101C9	190.75	18.64	3.24	0.32	0.81
liver, fetal, pool1	10086-102B5	166.51	5.64	2.82	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	487.05	20.27	2.04	0.73	1.02
locus coeruleus, adult, donor10252	10165-103B3	216.66	20.49	3.32	2.77	1.48
locus coeruleus, adult, donor10258	10375-105G6	447.19	19.75	1.69	3.10	1.69
locus coeruleus, newborn, donor10223	10362-105F2	418.10	25.24	4.63	1.68	0.42
lung adenocarcinoma cell line:A549	10499-107C4	124.00	8.30	0.69	0.28	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	119.27	5.52	6.89	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	200.76	13.84	1.19	0.79	0.13
lung, adult, pool1	10019-101D1	431.28	42.53	1.06	1.18	0.95
lung, fetal, donor1	10068-101I5	221.19	27.40	2.00	2.00	0.57
lung, right lower lobe, adult, donor1	10075-102A3	610.80	41.24	0.46	0.46	2.29
lymph node, adult, donor1	10077-102A5	446.85	12.78	0.47	1.42	0.95
lymphangiectasia cell line:DS-1	10727-110A7	245.26	5.26	0.66	0.66	1.32
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	247.52	10.26	3.62	1.36	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	357.64	21.24	4.25	0.00	0.00
mature adipocyte, donor1	12231-129F8	165.16	12.88	0.89	0.00	0.00
mature adipocyte, donor2	12232-129F9	174.12	6.64	0.42	0.62	0.00
mature adipocyte, donor3	12233-129G1	125.64	11.62	0.71	0.24	0.24
mature adipocyte, donor4	12234-129G2	181.88	9.21	2.11	0.26	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	411.47	19.54	9.29	0.00	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	450.08	32.71	6.77	1.13	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	476.13	35.86	6.25	1.47	1.47
medial frontal gyrus, adult, donor10258	10368-105F8	509.89	10.48	5.40	3.18	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	286.17	28.57	5.54	2.99	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	453.26	42.19	2.03	5.91	3.04
medial temporal gyrus, adult, donor10252	10156-103A3	512.52	32.68	3.82	0.64	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	192.63	1.93	7.71	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	789.45	71.77	0.00	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	375.08	26.92	3.23	1.44	0.36
medulla oblongata - adult, donor10196	10174-103C3	285.55	16.22	1.30	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	234.99	20.74	3.10	1.24	0.77
medulla oblongata, adult, pool1	10038-101F2	198.84	22.28	3.43	1.71	1.06
medulla oblongata, newborn, donor10223	10361-105F1	267.68	15.97	3.12	1.04	1.04
medulloblastoma cell line:D283 Med	10838-111E1	246.43	32.99	3.32	3.54	2.44
medulloblastoma cell line:ONS-76	10759-110E3	98.43	1.59	0.49	0.12	0.12
melanoma cell line:COLO 679	10514-107E1	199.66	18.40	0.86	0.43	0.14
melanoma cell line:G-361	10465-106H6	215.54	25.25	1.09	1.36	0.00
meningioma cell line:HKBMM	10691-109F7	114.15	15.38	0.00	1.27	0.90
merkel cell carcinoma cell line:MKL-1	10843-111E6	338.36	55.51	5.29	2.64	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	199.34	41.73	5.44	4.93	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	36.82	13.81	0.00	1.07	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	33.63	14.36	0.36	1.27	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	23.19	8.70	0.83	1.24	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	23.32	13.63	0.28	0.84	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	33.89	13.09	0.58	1.73	0.96
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	50.67	9.72	2.08	1.39	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	37.93	13.04	0.51	1.54	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	38.88	15.07	1.38	1.38	0.92
mesenchymal precursor cell - cardiac, donor3	11754-123G8	33.42	12.34	0.40	1.59	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	27.28	10.13	0.41	1.08	0.81
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	33.86	11.52	0.71	1.00	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	103.42	17.46	0.00	1.65	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	34.32	13.42	0.00	0.55	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	90.41	16.76	1.05	1.40	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	28.79	15.92	0.00	1.02	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	79.08	9.71	2.16	1.08	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	52.24	18.10	0.10	2.07	1.03
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	38.07	5.02	0.23	0.46	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	15.52	8.39	0.42	0.84	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	24.51	15.24	0.60	0.60	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	38.16	18.73	0.35	2.10	1.14
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	110.45	11.04	0.37	2.95	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	63.53	10.59	0.86	2.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	125.88	9.26	1.26	4.63	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	66.67	8.22	0.46	0.91	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	68.55	11.25	0.00	1.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	63.08	13.87	1.05	0.52	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	59.46	11.09	0.92	1.54	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	54.37	14.59	1.65	0.71	1.41
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	57.54	7.78	0.00	2.03	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	66.02	10.61	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	61.17	12.51	1.85	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	63.74	12.69	0.58	1.44	1.15
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	51.54	10.26	1.12	1.34	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	59.61	12.02	0.72	1.92	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	47.67	11.00	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	64.78	15.10	0.34	0.67	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	53.63	12.69	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	55.41	12.89	0.43	0.86	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	60.16	5.47	5.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	46.48	5.16	0.00	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	74.05	9.09	0.65	0.97	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	106.21	10.18	1.45	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	151.39	12.79	0.53	1.60	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	75.23	7.36	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	109.62	9.33	0.39	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	77.65	10.49	2.10	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	96.37	6.95	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	71.51	14.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	107.92	9.49	0.00	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	75.54	10.97	0.00	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	115.28	8.23	0.63	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	115.54	11.04	0.34	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	96.71	12.90	0.00	2.15	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	87.82	3.99	0.00	11.98	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	68.88	10.33	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	87.61	11.82	0.41	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	101.69	7.94	0.00	3.18	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	85.48	8.25	0.00	1.77	1.77
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	116.27	9.97	0.31	1.25	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	104.26	9.36	0.00	6.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	69.78	9.46	0.00	1.18	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	69.34	5.14	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	53.01	7.57	0.00	1.38	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	95.00	8.41	1.98	0.99	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	49.35	5.61	1.12	3.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	83.96	10.18	0.00	0.64	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	84.63	6.85	2.42	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	87.22	8.72	2.18	2.18	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	65.89	7.60	1.27	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	96.50	10.92	0.61	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	126.53	13.56	0.00	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	122.73	6.59	0.82	1.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	134.33	20.64	0.79	1.59	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	141.15	8.44	1.62	0.32	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	108.99	6.11	0.00	3.06	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	128.44	23.21	3.09	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	322.47	19.61	0.94	0.24	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	184.88	15.75	0.70	0.46	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	85.47	17.09	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	76.34	3.90	0.62	0.31	0.10
mesothelioma cell line:Mero-25	10850-111F4	69.67	9.76	0.23	0.68	0.68
mesothelioma cell line:Mero-41	10851-111F5	76.52	11.49	0.98	1.71	0.24
mesothelioma cell line:Mero-48a	10852-111F6	61.56	5.09	0.66	0.66	0.44
mesothelioma cell line:Mero-82	10853-111F7	141.91	14.45	0.53	2.10	1.05
mesothelioma cell line:Mero-83	10854-111F8	90.56	7.15	0.68	0.68	1.02
mesothelioma cell line:Mero-84	10855-111F9	58.39	6.32	0.25	0.76	0.25
mesothelioma cell line:Mero-95	10856-111G1	95.24	9.11	1.24	1.04	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	69.57	9.61	0.50	0.66	0.33
mesothelioma cell line:NCI-H226	10846-111E9	58.64	10.14	0.18	1.09	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	69.87	8.71	0.85	0.51	0.51
mesothelioma cell line:NCI-H28	10845-111E8	48.35	7.13	1.53	1.02	0.51
mesothelioma cell line:No36	10857-111G2	55.78	4.57	1.96	0.33	0.33
mesothelioma cell line:ONE58	10858-111G3	80.47	6.50	1.08	0.00	0.27
migratory langerhans cells, donor1	11901-125F2	169.08	5.57	0.38	2.11	0.58
migratory langerhans cells, donor2	11902-125F3	167.18	6.35	0.37	2.56	0.24
migratory langerhans cells, donor3	11903-125F4	175.35	10.23	1.08	1.44	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	222.99	33.30	0.33	8.81	1.96
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	153.23	4.24	0.00	0.64	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	229.90	4.84	0.69	0.23	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	242.43	8.56	1.33	0.57	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	289.94	20.51	1.48	2.03	0.55
myeloma cell line:PCM6	10474-106I6	167.62	22.93	0.20	2.17	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	123.27	4.06	1.01	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	106.11	7.65	1.18	0.98	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	160.90	19.05	0.33	2.01	0.67
nasal epithelial cells, donor1, tech_rep2	12226-129F3	183.04	17.06	0.44	1.40	0.59
nasal epithelial cells, donor2	12227-129F4	193.20	23.18	0.00	1.10	0.00
neuroblastoma cell line:CHP-134	10508-107D4	567.56	35.20	3.91	0.46	0.23
neuroblastoma cell line:NB-1	10539-107G8	253.13	26.00	5.24	0.56	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	93.63	10.12	1.48	0.84	0.42
neuroblastoma cell line:NH-12	10555-107I6	187.28	15.28	2.05	1.49	1.49
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	203.30	8.78	3.56	1.19	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	255.78	9.34	1.43	0.95	1.27
neuroectodermal tumor cell line:TASK1	10774-110F9	212.93	5.03	4.83	1.61	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	204.08	4.45	1.91	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	261.91	4.52	0.53	0.00	0.00
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	26.56	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	28.41	18.94	0.00	0.00	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	251.82	28.75	2.03	1.18	1.52
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	124.88	15.21	0.80	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	189.80	10.58	1.28	1.60	1.28
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	76.99	15.24	0.53	2.63	1.05
nucleus accumbens, adult, pool1	10037-101F1	256.56	30.93	2.91	1.59	0.84
occipital cortex - adult, donor10196	10172-103C1	991.04	35.03	10.30	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	623.41	39.72	4.56	1.07	1.61
occipital cortex, newborn, donor10223	10355-105E4	508.79	34.21	5.46	1.82	0.36
occipital lobe, adult, donor1	10076-102A4	1900.82	318.55	5.77	1.05	0.26
occipital lobe, fetal, donor1	10073-102A1	1453.79	60.07	3.86	3.00	0.00
occipital pole, adult, pool1	10036-101E9	408.56	50.22	7.10	2.84	1.81
olfactory region, adult	10195-103E6	272.44	15.86	2.10	1.91	0.57
optic nerve, donor1	10277-104E7	710.37	56.03	6.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	78.14	11.62	2.05	0.46	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	94.52	7.01	0.69	0.55	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	110.06	4.23	1.35	1.02	0.68
oral squamous cell carcinoma cell line:SAS	10544-107H4	70.23	7.62	0.35	0.92	0.69
osteoclastoma cell line:Hs 706.T	10704-109H2	163.74	28.51	1.47	2.35	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	328.89	19.62	2.80	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	147.17	6.36	1.48	0.42	0.00
ovary, adult, pool1	10020-101D2	413.35	47.34	1.05	2.18	1.31
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	269.48	6.05	0.73	0.37	0.00
pancreas, adult, donor1	10049-101G4	475.02	23.52	1.88	5.64	5.64
pancreatic carcinoma cell line:NOR-P1	10698-109G5	257.45	26.56	0.28	0.56	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	78.70	6.13	1.19	2.21	1.19
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	281.66	12.58	0.83	0.66	0.50
paracentral gyrus, adult, pool1	10035-101E8	335.06	39.26	5.40	2.84	1.46
parietal cortex, adult, donor10258	10373-105G4	160.01	0.73	3.67	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	392.18	29.15	4.70	2.82	1.88
parietal lobe, adult, donor10252	10157-103A4	476.58	45.32	4.85	2.85	1.43
parietal lobe, adult, pool1	10034-101E7	300.93	38.24	5.29	1.23	1.23
parietal lobe, fetal, donor1	10072-101I9	1543.01	33.94	1.94	6.79	3.88
parietal lobe, newborn, donor10223	10356-105E5	373.86	19.07	2.99	1.50	0.75
parotid gland, adult	10199-103F1	310.80	74.62	1.23	1.85	3.08
penis, adult	10200-103F2	228.81	35.45	1.07	0.54	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	127.37	11.53	1.67	1.86	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	155.46	3.35	1.02	0.44	0.29
pineal gland - adult, donor10196	10179-103C8	287.04	19.35	3.87	0.00	0.65
pineal gland, adult, donor10252	10160-103A7	565.56	29.02	4.15	3.55	1.78
pineal gland, adult, donor10258	10377-105G8	252.71	11.29	10.03	1.88	0.00
pituitary gland - adult, donor10196	10180-103C9	245.87	33.39	3.04	2.02	0.00
pituitary gland, adult, donor10252	10162-103A9	526.91	29.19	6.25	1.56	1.04
pituitary gland, adult, donor10258	10378-105G9	280.91	7.66	7.66	0.00	0.00
placenta, adult, pool1	10021-101D3	196.09	13.65	2.37	0.75	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	141.03	13.38	1.99	1.06	0.66
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	223.03	13.23	0.16	0.47	0.16
pons, adult, pool1	10033-101E6	220.59	28.75	3.18	1.20	0.86
postcentral gyrus, adult, pool1	10032-101E5	414.96	53.70	4.27	2.70	1.83
promyelocytes/myelocytes PMC, donor1	12132-128D8	35.55	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	27.54	11.02	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	121.92	9.76	1.02	0.87	0.58
prostate cancer cell line:PC-3	10439-106E7	206.00	14.16	1.09	0.36	0.00
prostate, adult, pool1	10022-101D4	476.95	46.43	2.63	2.27	0.54
putamen, adult, donor10196	10176-103C5	183.66	12.28	2.12	1.18	1.42
putamen, adult, donor10252	10152-102I8	264.70	35.29	0.00	5.88	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	102.72	0.00	7.65	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	231.46	13.05	3.14	0.97	0.72
putamen, newborn, donor10223	10365-105F5	396.57	25.49	6.00	2.25	0.75
rectal cancer cell line:TT1TKB	10469-106I1	230.13	10.18	0.87	0.29	0.29
rectum, fetal, donor1	10067-101I4	571.70	20.86	0.00	0.00	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	53.42	5.09	1.06	0.85	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	191.37	20.71	0.00	5.38	0.00
retina, adult, pool1	10030-101E3	312.81	36.78	2.58	2.58	1.89
retinoblastoma cell line:Y79	10475-106I7	228.63	19.49	4.68	2.08	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	77.58	2.58	1.11	0.49	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	427.42	25.03	6.75	0.00	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	260.70	25.77	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	129.97	16.83	0.65	1.13	1.29
salivary acinar cells, donor2	11772-123I8	135.48	18.04	0.96	1.51	0.69
salivary acinar cells, donor3	11773-123I9	231.72	15.23	1.99	0.00	0.00
salivary gland, adult, pool1	10093-102C3	109.24	18.87	1.14	2.86	1.72
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	54.80	5.90	1.01	0.17	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	76.17	6.82	0.59	0.12	0.12
seminal vesicle, adult	10201-103F3	506.32	55.55	0.53	1.59	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	61.22	4.37	0.97	1.94	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	104.68	5.03	0.25	2.01	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	99.35	8.03	1.00	2.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	91.61	22.16	1.48	0.54	0.94
signet ring carcinoma cell line:Kato III	10436-106E4	66.21	6.85	0.55	0.44	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	132.90	8.64	0.90	0.52	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	243.30	20.57	0.00	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	484.07	38.50	1.32	0.84	0.36
skeletal muscle, fetal, donor1	10066-101I3	644.22	16.08	3.02	0.00	2.01
skin, adult, donor1	10074-102A2	970.28	20.36	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	426.71	20.20	0.63	1.26	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	252.81	10.34	2.00	1.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	181.56	11.66	3.47	1.58	1.89
small cell lung carcinoma cell line:DMS 144	10841-111E4	50.11	8.67	0.96	0.96	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	218.73	13.68	2.31	0.82	0.82
small cell lung carcinoma cell line:NCI-H82	10842-111E5	216.18	27.83	1.61	1.45	0.97
small cell lung carcinoma cell line:WA-hT	10562-108A4	112.23	8.06	1.31	2.18	0.65
small intestine, adult, pool1	10024-101D6	440.63	36.43	1.55	0.96	0.60
small intestine, fetal, donor1	10064-101I1	432.18	8.60	1.23	1.47	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	75.91	7.18	3.59	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	433.69	12.15	0.00	3.62	2.07
somatostatinoma cell line:QGP-1	10781-110G7	177.16	3.75	3.22	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	667.34	22.02	3.44	1.38	1.15
spinal cord, adult, donor10252	10159-103A6	431.73	25.63	2.76	0.79	0.79
spinal cord, adult, donor10258	10369-105F9	98.93	1.38	3.46	1.38	0.00
spinal cord, fetal, donor1	10056-101H2	642.77	30.49	6.10	1.83	0.00
spinal cord, newborn, donor10223	10359-105E8	219.50	11.94	9.18	0.92	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	170.71	5.82	0.75	0.15	0.30
spleen, adult, pool1	10025-101D7	304.85	27.09	1.65	1.10	0.55
spleen, fetal, pool1	10044-101F8	195.94	20.98	0.72	0.64	0.87
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	84.05	6.31	0.31	0.52	0.72
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	247.79	13.29	0.57	1.14	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	159.35	9.78	1.75	1.40	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	213.45	7.04	0.78	1.56	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	214.42	17.00	5.29	0.23	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	166.05	8.90	0.42	0.85	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	137.07	7.19	0.85	0.42	0.00
stomach, fetal, donor1	10062-101H8	583.11	13.88	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	227.87	42.16	0.57	1.71	1.14
substantia nigra - adult, donor10196	10178-103C7	488.47	0.00	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	186.52	24.51	1.45	2.91	1.87
substantia nigra, adult, donor10258	10371-105G2	94.66	1.55	5.69	2.07	0.52
substantia nigra, newborn, donor10223	10358-105E7	429.60	16.25	2.83	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	173.55	12.84	0.92	0.92	0.23
temporal lobe, adult, pool1	10031-101E4	332.89	30.09	5.17	1.44	1.36
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	1622.55	54.13	3.56	4.99	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	493.16	51.87	3.08	5.27	1.76
tenocyte, donor1	11763-123H8	82.39	5.93	1.40	2.79	1.75
tenocyte, donor2	11765-123I1	91.56	11.45	0.38	5.34	0.38
tenocyte, donor3	11768-123I4	63.75	6.67	1.11	0.74	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	185.26	5.78	2.38	1.36	0.85
teratocarcinoma cell line:NCR-G1	10798-110I6	283.02	8.63	4.16	1.08	1.08
teratocarcinoma cell line:PA-1	10807-111A6	280.97	8.06	4.34	1.24	0.93
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	228.89	9.65	2.29	0.00	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	80.93	12.10	3.03	0.38	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	101.32	20.61	0.44	0.65	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	110.09	8.14	2.61	0.65	0.65
testis, adult, pool1	10026-101D8	636.40	78.17	8.48	2.04	1.50
testis, adult, pool2	10096-102C6	243.13	27.97	12.63	3.16	1.80
thalamus - adult, donor10196	10168-103B6	303.60	23.18	5.52	0.00	1.10
thalamus, adult, donor10252	10154-103A1	203.95	20.94	2.97	1.41	1.09
thalamus, adult, donor10258, tech_rep1	10370-105G1	113.93	3.08	15.40	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	311.76	14.82	1.81	2.14	0.49
thalamus, newborn, donor10223	10366-105F6	329.66	17.26	5.75	0.00	0.00
throat, adult	10209-103G2	238.68	47.94	1.75	1.00	0.25
throat, fetal, donor1	10061-101H7	625.26	13.41	1.83	0.30	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	126.79	17.89	0.99	0.79	0.60
thymus, adult, pool1	10027-101D9	436.53	53.29	3.38	1.99	1.19
thymus, fetal, pool1	10043-101F7	339.46	30.34	2.70	1.25	0.94
thyroid carcinoma cell line:KHM-5M	10776-110G2	105.44	16.89	0.00	1.46	0.93
thyroid carcinoma cell line:TCO-1	10783-110G9	160.09	5.31	0.84	0.84	0.28
thyroid, adult, pool1	10028-101E1	686.97	76.52	4.76	3.27	2.52
thyroid, fetal, donor1	10060-101H6	686.58	15.56	2.11	0.53	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	708.31	52.35	0.00	0.00	0.00
tongue, adult	10203-103F5	174.67	31.17	0.47	1.40	0.93
tongue, fetal, donor1	10059-101H5	413.40	8.28	0.39	0.00	0.39
tonsil, adult, pool1	10047-101G2	280.09	23.84	1.10	1.30	1.10
trachea, adult, pool1	10029-101E2	297.09	25.93	1.15	1.64	0.41
trachea, fetal, donor1	10058-101H4	608.97	21.54	1.54	1.15	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	141.71	14.53	0.35	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	137.79	10.54	1.82	0.10	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	347.53	27.58	0.94	1.10	0.94
tridermal teratoma cell line:HGRT	10694-109G1	279.67	32.34	0.00	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	193.34	3.98	1.19	0.59	0.34
umbilical cord, fetal, donor1	10057-101H3	300.46	2.09	2.09	0.00	2.09
uterus, adult, pool1	10100-102D1	173.36	26.79	2.39	3.07	0.68
uterus, fetal, donor1	10055-101H1	628.14	19.97	2.56	1.54	2.05
vagina, adult	10204-103F6	371.56	81.42	1.94	0.65	1.94
vein, adult	10191-103E2	298.55	37.92	0.66	0.66	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	63.02	4.27	0.00	1.34	0.27